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The development of high-throughput sequencing techniques and continued decrease of associated costs, 
together with advances in bioinformatics and increasing availability of powerful software for nucleotide 
and amino acid sequence analyses contributed to the exponential increase of available microbial 
genomes. These developments have unveiled several novel sequences presenting a size within the range 
of 50-500 nucleotides (nt) and encoding the now called small non-coding regulatory RNAs (sRNAs). 
These sRNAs are frequently encoded in intergenic regions, often partially overlapping with the 5’ or 3’ 
untranslated regions of the vicinal genes or annotated-opening reading frames (ORFs). The current 
known function for some sRNAs comprises the gene expression regulation through interference RNA 
mechanisms, mainly at the posttranscriptional level. 
Bacterial sRNAs may regulate their targets (messenger RNAs) through positive or negative regulation 
mechanisms. To carry out a negative regulation, the sRNA base pairs with its target in the region 
containing the initiation codon and/or the ribosome-binding site (RBS), precluding the ribosome binding 
and consequently preventing the mRNA translation.  
The Burkholderia cepacia (Bcc) complex comprises nowadays 20 validated and phylogenetically-
related species of Gram-negative bacteria. These bacteria are phenotypically similar and genotypically 
distinct, being widely distributed in different ecological niches such as soil, water, plants, animals and 
in humans. Some Bcc bacteria have potential application as bioremediation and biocontrol/biopesticides 
agents due to their unusual metabolic abilities, which include xenobiotics metabolism, production of 
antifungal compounds and promotion of plant growth. 
However, Burkholderia species have emerged in 1980s as important opportunistic pathogens, especially 
to cystic fibrosis (CF) patients. Bcc bacteria have gained the attention of medical and scientific 
community because they can cause in CF patients a rapid evolving clinical state known as the cepacia 
syndrome, which can cause a fast and necrotizing pneumonia, septicemia and ultimately results in the 
patient early death. Bcc bacteria produce a wide variety of virulence factors, possessing intrinsic 
resistance mechanisms to different antibiotics which lead to a difficult eradication. Over the last years, 
some Bcc species have also been recognized as emerging nosocomial pathogenic agents in hospitalized 
non-CF patients, particularly in cancer patients. 
To identify potential genes involved in the Bcc bacteria virulence, researchers from iBB (Instituto de 
Bioengenharia e Biociências) prepared mutant libraries derived from B. contaminans IST408 and B. 
cenocepacia J2315 by random plasposon mutagenesis. This work aims to characterize a mutant derived 
from B. cenocepacia J2315, identified in an attenuated virulence screening using as model of infection 
the nematode Caenorhabditis elegans. This mutant, B. cenocepacia SJ2, contains the plasposon inserted 
in the intergenic region of B. cenocepacia J2315 chromosome 1, located between the coding gene of 
DNA gyrase subunit A (GyrA) enzyme and the coding gene of an outer membrane protein of the OmpA 
family. 
Bioinformatic and Southern blot analyses allowed the identification of the plasposon insertion in the 
mutant B. cenocepacia SJ2. The plasposon is located 8 nucleotides (nt) after the predicted 5’ UTR 
beginning of the B. cenocepacia J2315 OmpA-like protein. Therefore, the presence and functionality of 
the transcript ompA were evaluated by RT-PCR and Western blot, respectively. The results obtained 
indicated that the plasposon insertion did not affect ompA mRNA transcription or functionality. 
Bioinformatic analyses also led to the identification of a possible opening reading frame (ORF) in the 
complementary strand (named ORF3) and encoding a 93 amino acids protein. The presence of this ORF 
was supported by Northern blot assays previously performed. These assays allowed the identification of 
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a transcript from the complementary strand. However, the amplification of complementary DNA ends 
(5’ and 3’ RACE) using specific primers for ORF3 region demonstrated that the transcript in study has 
a 5’ end with a lower size than the expected transcript of the potential protein (ORF3). A transcript 
containing approximately 179 base pairs and non-interrupted by the plasposon was identified. In the 
presence of these results, primers for the potential DNA sequence of ORF3 were designed and the results 
showed that this is the region interrupted by the plasposon. 
Due to the absence of initiation and termination codons in the region closer to the 179 base pairs 
transcript, it was hypothesized that the transcript corresponds to a sRNA (MavA). In this work, the 
presence of two genetic elements, a sRNA and a protein, in the intergenic region of B. cenocepacia 
J2315 chromosome 1 is described. The coding sequences of both the sRNA and protein are overlapped 
in, at least, 100 nucleotides.  
Bioinformatic analysis of the genetic elements showed that they are conserved among the Burkholderia 
genus. Moreover, the sequence of ORF3 protein also showed to be identical to the sequence of one 
protein encoded by an annotated ORF in the B. multivorans genome and to five proteins of B. 
pseudomallei. 
The assays performed with the strain containing the ORF3 interrupted by the plasposon revealed the 
involvement of this protein in the resistance of B. cenocepacia J2315 strain to heat-shock stress (50 ºC), 
susceptibility to the detergent sodium dodecyl sulphate (SDS), biofilms formation, cellular 
hydrophobicity and antibiotics resistance (imipenem, ceftazidime and tetracycline). In general, these 
results suggest that this protein is likely involved in the maintenance of the outer membrane integrity 
and virulence of B. cenocepacia J2315 towards the nematode C. elegans.  
MavA sRNA identified in the work herein presented was predicted to be a functional homologue of 
IstR-2 sRNA of Escherichia coli K-12 MG1655. Preliminary results of the MavA sRNA overexpression 
characterization indicate a possible direct or indirect role in the overexpression of ribosomal protein 
S12. Phenotypic analysis also showed the involvement in the swimming motility of B. cenocepacia 
J2315 strain and in resistance to thermal (50 ºC) stress. In addition, this sRNA is not involved in the 
virulence of B. cenocepacia J2315 towards the C. elegans nematode. 
Overall, the results presented in this study contribute to a better knowledge of the intergenic region 
under study and to the identification of a putative ORF and a sRNA, contributing to a better 
understanding of the biology of Bcc bacteria and the role of sRNAs in the regulation of the expression 
of putative virulence factors. The identification of MavA sRNA and ORF3 protein highlight the 
importance of these studies in identifying genetic elements that might be exploited as targets for the 
development of effective treatments to the B. cenocepacia J2315 strain infections.  
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O recente desenvolvimento de técnicas de elevado rendimento para sequenciar genomas e a diminuição 
contínua do custo associado, conjuntamente com os avanços na bioinformática e a disponibilidade de 
número crescente de ferramentas bioinformáticas para análise de sequências nucleotídicas e 
aminoacídicas, tornou possível o aumento exponencial dos genomas microbianos disponíveis. 
Consequentemente, têm vindo a ser descobertos diversos pequenos transcritos com ação regulatória 
denominados de pequenos RNAs reguladores não codificantes (sRNAs), com tamanhos compreendidos 
entre 50-500 nucleótidos. Estes sRNAs têm sido identificados essencialmente em regiões intergénicas, 
junto a genes ou grelhas de leitura (ORFs) anotadas. A função conhecida de um grupo importante desses 
sRNAs consiste na regulação da expressão génica, principalmente ao nível pós-transcricional, por 
mecanismos de interferência de RNA.  
Os sRNAs bacterianos podem exercer nos seus alvos (RNAs mensageiros) uma regulação positiva ou 
negativa. No caso de ser exercida uma regulação negativa o sRNA estabelece com o seu alvo um 
emparelhamento na região que contém o codão de iniciação e/ou a região de ligação do ribossoma 
(RBS), tornando este local inacessível para a ligação do ribossoma e impedindo, assim, a tradução do 
mRNA. 
O complexo Burkholderia cepacia (Bcc) é atualmente constituído por 20 espécies de bactérias Gram-
negativas validadas e filogeneticamente próximas. As bactérias que compõem este grupo são 
fenotipicamente semelhantes e genotipicamente distintas, podendo ser isoladas de várias fontes. São 
exemplo de fontes o solo, a água, a rizosfera de plantas, animais e Humanos. Devido às suas capacidades 
metabólicas invulgares, algumas estirpes do Bcc apresentam um elevado potencial de aplicação ao nível 
do biocontrolo, biorremediação e agricultura, pois são capazes de metabolizar xenobióticos, produzir 
compostos com atividade antifúngica e promover o crescimento de plantas. 
Contudo, na década de 80 as bactérias incluídas no género Burkholderia, incluindo as englobadas no 
complexo Bcc, emergiram como agentes patogénicos oportunistas em indivíduos com fibrose quística 
(FQ).  
O facto de as bactérias deste complexo produzirem vários fatores de virulência, apresentarem 
mecanismos de resistência a um largo espetro de antibióticos sendo difíceis de erradicar e de causarem 
em doentes com FQ infeções por vezes acompanhadas por um estado clínico de evolução rápida que 
inclui pneumonia necrotizante e septicémia, levando à morte do doente – síndrome cepacia -, faz com 
que tenham merecido uma elevada atenção da comunidade médica e científica. Acresce que algumas 
espécies do Bcc têm vindo a ser reconhecidas nos últimos anos como sendo agentes patogénicos 
nosocomiais emergentes em doentes hospitalizados, principalmente em doentes oncológicos.  
Com o objetivo de identificar possíveis genes envolvidos na virulência de bactérias do Bcc, 
investigadores do iBB (Instituto de Bioengenharia e Biociências) construíram bibliotecas de mutantes 
de B. contaminans IST408 e B. cenocepacia J2315 utilizando plasposões. As bibliotecas de mutantes 
foram rastreadas tendo como objetivo a identificação de mutantes que exibiam virulência atenuada, 
utilizando como modelo de infeção o nemátodo Caenorhabditis elegans. O trabalho aqui apresentado 
teve como objetivo a caracterização de um mutante identificado no rastreio acima mencionado, contendo 
um plasposão inserido na região intergénica do cromossoma 1 de B. cenocepacia J2315, localizada entre 
o gene codificante da subunidade A da enzima ADN girase (GyrA) e o gene codificante de uma proteína 
da membrana externa do tipo A (OmpA). 
Através de análises bioinformáticas e experimentais, foi possível localizar no mutante B. cenocepacia 
SJ2 a inserção do plasposão 8 nucleótidos (nt) após o início da região 5’ não traduzida (5’ UTR) do gene 
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que codifica a proteína do tipo OmpA. Neste sentido, foram avaliados a presença e a funcionalidade do 
transcrito ompA por ensaios de RT-PCR e Western blot, respetivamente. Os resultados obtidos 
confirmaram que a inserção do plasposão não afetou a transcrição nem a funcionalidade do transcrito 
correspondente ao gene ompA.  
As análises bioinformáticas realizadas permitiram ainda a identificação de uma possível grelha de leitura 
aberta (ORF) na cadeia complementar da região intergénica (designada de ORF3), codificando para uma 
proteína de aproximadamente 93 aminoácidos. A confirmação da presença desta ORF foi suportada por 
ensaios de Northern blot realizados anteriormente e que permitiram a identificação de um transcrito a 
partir da cadeia complementar. No entanto, análises de amplificação em cadeia pela polimerase (PCR) 
das extremidades do ADN complementar (5’ e 3’ RACE) com sequências oligonucleotídicas iniciadoras 
específicas para a região da ORF3 demonstraram que o transcrito em causa possui uma extremidade 5’ 
menor que o esperado para o transcrito da possível proteína (ORF3), permitindo assim a identificação 
de um transcrito com cerca de 179 pares de bases que se verificou não ser interrompido pelo plasposão. 
Deste modo, tendo em conta os resultados aqui apresentados foram desenhadas sequências 
oligonucleotídicas iniciadoras específicas para a sequência de ADN da possível ORF3, tendo-se 
verificado que esta era a região interrompida pelo plasposão. 
Devido à ausência de codões de iniciação e de terminação na região próxima do transcrito de 179 pares 
de base, colocou-se a hipótese deste transcrito corresponder a outro elemento genético, nomeadamente 
um sRNA, que se denominou de MavA. Neste trabalho é descrita a existência de dois elementos 
genéticos na região intergénica do cromossoma 1 de B. cenocepacia J2315, um sRNA e um gene que 
codifica uma proteína, sendo que as sequências codificantes de ambos encontram-se parcialmente 
sobrepostas em, pelo menos, 100 nucleótidos. 
As análises bioinformáticas realizadas dos elementos genéticos permitiram a sua identificação como 
sendo ambos conservados no género Burkholderia. Além disso, demonstraram também que a proteína 
ORF3 é idêntica à sequência de uma proteína codificada por uma ORF anotada no genoma de B. 
multivorans e à de cinco proteínas de B. pseudomallei. 
Ensaios realizados com a estirpe contendo o plasposão a interromper a ORF3 demonstraram que esta 
proteína está envolvida na resistência da estirpe B. cenocepacia J2315 a choque térmico (50 ºC), 
suscetibilidade à presença do detergente dodecil sulfato de sódio (SDS), capacidade para formação de 
biofilmes e hidrofobicidade das células, bem como na resistência a antibióticos (imipeneme, ceftazidima 
e tetraciclina). De um modo geral, estes resultados apontam para que esta proteína esteja envolvida na 
manutenção da integridade da membrana externa e virulência da estirpe B. cenocepacia J2315 para o 
nemátodo C. elegans.  
O sRNA MavA identificado neste trabalho foi bioinformaticamente previsto como tendo como seu 
homólogo funcional o sRNA IstR-2 de Escherichia coli K-12 MG1655. Os resultados preliminares da 
caracterização do sRNA MavA através da sua sobrexpressão demonstram um possível envolvimento 
direto ou indireto na sobrexpressão da proteína ribossomal S12. As análises fenotípicas mostraram ainda 
o seu envolvimento na mobilidade da estirpe B. cenocepacia J2315 por swimming e na resistência ao 
choque térmico (50 ºC). Os resultados obtidos, baseados em ensaios de morte lenta do nemátodo C. 
elegans sugerem que este sRNA não está envolvido na virulência de B. cenocepacia J2315 neste modelo 
animal de infeção. 
Os resultados obtidos no presente trabalho contribuem para um conhecimento mais aprofundado da 
região intergénica estudada, tendo permitido identificar 2 elementos genéticos parcialmente sobrepostos 
que codificam uma proteína e um sRNA. Este trabalho constitui assim um contributo para o melhor 
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conhecimento da biologia das bactérias do complexo Bcc e do papel dos sRNAs na regulação da 
expressão de fatores de virulência. A identificação do sRNA MavA e da proteína ORF3 realça a 
importância deste tipo de estudos na identificação de elementos genéticos que possam ser explorados 
como alvos para o desenvolvimento de estratégias terapêuticas mais eficazes com vista ao tratamento 
das infeções causadas pela estirpe B. cenocepacia J2315. 
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1.1 Cells harbour different classes of RNAs 
The work developed by Hoagland et al. [1] has played a major role in helping us to understand the DNA 
translation mechanism to proteins. Transfer RNAs (tRNAs) were first described by this research group 
as “soluble RNAs” that when bound to amino acids (aa) caused their activation. However, an important 
piece of the puzzle was still missing and it was only in 1961 that the concept of messenger RNA (mRNA) 
based on the Jacob-Monod Model [2] was biochemically demonstrated by  Brenner et al. [3] and Gros 
et al. [4]. 
Cells harbor several types of RNA molecules with different functions, which can be divided into two 
major classes i) protein coding RNAs and ii) non-coding RNAs [5]. These two classes are discriminated 
based on the presence or absence of an open reading frame (ORF), respectively [5–7]. mRNA contains 
the genetic information copied from DNA coded in triplets of “letters” and is the only RNA belonging 
to the class (i) [8]. Non-coding RNAs (ii) are a much more diverse group and due to their function as 
regulators in different steps of gene expression, they are recognized also as regulatory RNAs. Therefore, 
non-coding RNA class includes, among others, a) tRNAs which are responsible for the growth of the 
polypeptide chains due to the presence of a three base sequence that base pairs with its complementary 
triplet present in mRNA [1,8]; b) ribosomal RNAs (rRNAs) that are associated with proteins consisting 
of essential structures of the translation process - ribosomes, and c) small non-coding RNAs (sRNAs), 
a relatively new class of non-coding RNAs that can have housekeeping or exclusively 
posttranscriptional regulatory roles [9,10]. 
1.2 Bacterial small non-coding RNAs (sRNAs) 
Bacteria are present in different ecological niches where they are often exposed to changing and hostile 
environments such as those encountered during host infection processes. The changes that occur in these 
environments can be fast and enclose fluctuations in pH, nutrient availability, temperature and presence 
of reactive oxygen and nitrogen species (reviewed in [11,12]). 
However, bacteria can adapt to these conditions, i.e. they are able to maintain cellular homeostasis and 
thrive, due to modifications in gene and protein expression [7,13]. These alterations are caused by a 
regulation that can occur at different stages of gene expression (such as transcription and translation) 
and can affect mRNA stability, as well as DNA maintenance or silencing. The mechanisms involved in 
these gene regulatory networks are based on changes in RNA conformation, protein-DNA, RNA-RNA 
and RNA-DNA interactions (Fig. 1.1) (reviewed in [14]). 
Technical advances in nucleic acid sequencing methodologies have significantly contributed to the 
amount of known microbial genomes presently available. Consequently, it is possible to produce 
biocomputational genome-wide searches. Allied to these techniques, approaches relying on direct 
detection are important to define transcription start sites (TSS) and 5’ untranslated regions (5’ UTRs), 
such as tilling arrays and high-throughput RNA sequencing (RNAseq). These techniques allowed the 
discovery of sRNAs loci not only in several pathogenic and non-pathogenic bacteria but also in the other 
two domains of life (Archaea and Eukarya) [9,12,15,16]. 
sRNAs are an heterogeneous group of molecules [14]. They are primarily encoded in chromosomes, 
being most of them located in intergenic regions (IGRs), between annotated protein-coding genes and 
in the complementary strand of ORFs [17,18], although they have also been found in plasmids [19]. 
There are two relevant features in sRNAs namely a) their size and b) structure. Despite the absence of a 
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consensus among the authors about the size of these molecules, it is in general within the range of 50-
500 nucleotides (nt) [12,15,20]. Regarding its structure, sRNAs enclose an initial stable stem-loop and 
they are often associated with Rho-independent terminators of transcription which consist in a GC-rich 
stem-loop followed by a set of U’s. These stem-loops may be the main reason for the high stability 
observed in these molecules [21,22]. 
 
Figure 1.1 Schematic representation of the three levels of gene expression regulation involving regulatory RNAs. 
Transcription regulation is a process mainly mediated by protein-DNA interactions which occurs at the gene promoter region 
(i). Posttranscriptional regulation. The majority of the regulatory RNAs known so far act at this level of regulation causing 
conformational changes in the binding molecules or enzymes (ii). Posttranscriptional modification is relevant due to the fact 
that some proteins are produced in an inactive form and have to undergo covalent or conformational changes to display their 
activity (iii). Adapted from [23]. 
The majority of the sRNAs identified so far belong to Escherichia coli. Although their functions are not 
fully described, it has been shown that they mainly act as negative regulators of gene expression [21]. 
In fact, the first chromosomally encoded regulator identified was the E. coli MicF RNA, which binds 
imperfectly to the 5’ region of the ompF mRNA near the start codon. In view of this, translation of the 
mRNA encoding the major outer membrane porin F type (OmpF) is inhibited [24]. 
1.3 General regulatory RNAs classes  
In a first approach, two classes of regulatory non-coding RNAs can be distinguished based on the 
location of their target: cis-encoded and trans-encoded molecules. The cis-encoded molecules are RNA 
regulators encoded in the same genetic location of the target RNA (directly on the same - sense- or on 
the opposite strand - antisense), whereas trans-encoded refers to regulators that modulate the expression 
of a mRNA transcribed from a distinct genetic locus [12,14]. 
1.3.1 Regulatory 5’ UTR elements 
Riboswitches are a group of non-coding RNAs with a regulatory function. However, they are not a 
standard sRNA since they are transcribed from the 5’ UTR of the mRNA that they regulate, being cis-
encoded and cis-acting elements [25]. In response to several environmental signals, both chemical and 
physical, these regulatory elements change their conformation leading to the modulation of expression 
of downstream genes [25]. The riboswitch conformation is altered upon binding of the leader sequence 
to small molecules, repressing transcription or translation through the disruption of transcriptional 














RNA thermometers are a group of these molecules which specifically respond to fluctuations in 
temperature, being particularly important in pathogenic bacteria since the host body temperature induces 
expression of specific virulence genes [26]. Their regulation is achieved by an interchange between two 
conformations: a) “closed” structure, present at low temperatures where the Shine-Dalgarno (SD) 
sequence and/or AUG start codon are inaccessible for translation initiation and b) “open” structure, 
present at high temperatures when the secondary inhibitory structure around the RBS melts [12].  
These RNA elements are composed by the “aptamer region” domain which functions as ligand-binding 
domain and the “expression platform” domain, being the effector domain on the downstream genes [27]. 
1.3.2 Cis-encoded antisense sRNAs 
In addition to the environmental sensors aforementioned there is another class of cis-encoded RNA 
regulators, being the majority of them constitutively expressed [14]. sRNAs residing on plasmids were 
the first to be described as members of this class [28]. 
Their mechanism of action consists on base pairing with their target mRNAs. Since these sRNAs are 
mainly transcribed from the DNA strand opposite of their target, generally overlapping the 5’ end, they 
are named antisense sRNAs [13]. Consequently, they display extended regions of full complementarity 
with their target, around 75 or more nucleotides, and can exert a downregulation on the target genes. 
This downregulation can occur at the level of mRNA stability, transcription or translation (Fig. 1.2) 
[14]. 
 
Figure 1.2 Regulatory mechanisms employed by cis-encoded antisense sRNAs are based on two configurations. Base 
pairing between a sRNA (encoded opposite to the 5’ UTR of its target mRNA) and its target, prevents the ribosome binding to 
the RBS. This event inhibits the translation process and promotes sRNA-mRNA complex degradation (A). A few sRNAs are 
encoded in regions complementary to the sequence separating ORF’s (B) and base pairing of these sRNAs can target RNases 
causing mRNA cleavage (1) or transcriptional termination through the cessation of RNA polymerase activity due to a putative 
loop formation (2). In the last case, a reduction in the expression levels of downstream genes is induced. The grey arrows 
represent the promoter. Adapted from [14]. 
A few years ago, a new subset of these sRNAs was identified as negative regulators of the expression 
of mRNAs encoding potentially toxic proteins, when present in high intracellular concentrations [29]– 
























responsible for maintaining a low basal level of toxin expression. Although this mechanism is not fully 
understood, it is thought that it occurs substantially by a translation block (reviewed in [19,29]). 
In addition to the already mentioned role as antitoxin, the group of cis-encoded antisense sRNAs can 
also be involved in direct processing of mRNAs encoded in its opposite strands (Fig. 1.2. B1) [19]. The 
E. coli GadY is a cis-encoded RNA that it is encoded in the opposite strand of the operon gadXW, 
overlapping the 3’ end of the gadX mRNA [31]. Opdyke et al. [31] and Tramonti et al. [32] have shown 
that in cells in the stationary phase, the GadY antisense sRNA levels increase, promoting the generation 
of base pairing with the 3’ UTR of gadX mRNA. This binding promotes the cleavage of the duplex 
gadX-gadW, which is involved in the response to acidic conditions, increasing the intracellular levels of 
gadX transcript. Therefore, GadY acts as a positive posttranscriptional regulator of gadX.  
1.3.3 Trans-encoded sRNAs 
Unlike cis-encoded sRNAs, trans-encoded sRNAs are only expressed under stress conditions. These 
sRNAs have been encountered in specific conditions such as i) iron limitation [33], ii) oxidative stress 
[34], iii) low temperature [35] and iv) accumulation of non-metabolizable phosphoglucose molecules 
such as glucose-phosphate [36]. 
As already mentioned, trans-encoded sRNAs are encoded in a different genetic location relatively to 
their mRNA target [12,14]. In view of this, a limited complementarity is shared between the sRNA and 
its target, usually in discontinuous patches. In this case, the region where the sRNA overlaps the target 
mRNA is known as the “seed sequence” [19]. Seed regions of only 7 contiguous bases have been found 
for some sRNAs as being required for regulation [37,38]. 
The base pairing between sRNA and mRNA can result in positive or negative regulations. In both cases, 
mRNA translation and/or stability can be affected. However, the majority of trans-encoded sRNAs 
known so far, display a negative regulation through translational inhibition, mRNA degradation or both 
(Fig. 1.3). 
 
Figure 1.3 Regulatory mechanisms 
employed by trans-encoded sRNAs. 
The imperfect binding between the 
sRNA and its target is often linked with 
enzymes involved in the degradation of 
the duplex sRNA-mRNA, such as 
RNase E or RNase III (A). Trans-
encoded sRNAs can have positive 
effects in some targets through an anti-
antisense mechanism, which causes 
remodeling of the intrinsic inhibitory 
secondary structure covering the RBS 
and consequently allowing translation 
initiation (B). Besides the negative 
regulation through RNAs degradation, 
sRNAs can base pair with the SD 
sequence or the start codon of its target 
and sequester the RBS (C). The grey 
arrows represent the promoter. Adapted 
from [12]. 
Almost 50 years ago, Franze de Fernandz et al. [39] identified Hfq protein in E. coli as an important 
host factor to the replication of RNA bacteriophage Qβ. However, it was only in the last decade that this 


























positive and Gram-negative bacteria at the posttranscriptional level of regulation. This Sm-like protein 
appears to act as a mediator of the short and imperfect interaction established between trans-encoded 
sRNAs and their target mRNAs, due to their limited complementarity. In this case, it stimulates pairing 
between sRNA-mRNA by increasing the annealing rates (reviewed in [40]). The protein has the ability 
to bind not only sRNAs, but also mRNAs and in both cases it binds A-/U- rich sequences near hairpins 
[41]. Furthermore, Hfq is also involved in regulation through the modulation of the sRNA levels (Fig. 
1.4). 
Unlike what would be expected, the Hfq protein is not required in all cases of limited pairing but the 
reason behind this observation is still poorly understood. 
 
Figure 1.4 Major mechanisms of action of the RNA-binding protein Hfq. Hfq associates with a sRNA, creating a complex 
that interacts with the RBS of the target mRNA and inhibits translation (A). The complex sRNA-Hfq-mRNA disrupts the 
secondary structure present in the 5’ UTR region of the mRNA and enables the translation process (B). The turnover rate of 
sRNA and mRNA is modulated by Hfq through protection against degradation or by the recruitment of RNase E, respectively 
(C and D). Adapted from [40,42]. 
1.3.3.1 mRNAs 3’ regions are rich reservoirs for sRNAs 
The majority of sRNAs that have been investigated and characterized are encoded by free-standing 
genes located in IGRs and having a single output function associated. However, some protein-coding 
genes have been observed to possess dual-function since they produce from its 5’ region a mRNA 
template for translation and from its 3’ region a regulatory RNA, which will act as an antisense regulator 
on other mRNAs, through a shared promoter and/or terminator [43–46]. In the last years, a few examples 
of sRNAs overlapping mRNAs 3’ region were reported [47,48]. Recent studies based on co-
immunoprecipitation of Hfq and associated RNAs, allied to RNA-seq techniques with higher resolution, 
confirmed that mRNAs 3’ regions are large reservoirs for new sRNAs [49,50].  
Regarding their biogenesis, sRNAs that are originated from 3’ regions of known mRNAs can be 
distinguished into two different types: sRNAs transcribed from an insider promoter of the overlapping 
mRNA gene or 3’ UTR (type I) (Fig. 1.5 A) and sRNAs resulting from an internal processing of the 
initial mRNA (type II) (Fig.1.5 B). However, in both types there is a shared use of the Rho- independent 
transcription terminator present in the mRNA. The Salmonella dapB mRNA represents the first example 
of dual output via the 3’ UTR of a conserved gene being included in type I sRNAs, since DapZ sRNA 
overlaps the 3’ UTR of the dapB mRNA and is transcribed from an mRNA-internal promoter that exists 
upstream of the stop codon of the conserved dapB gene (Fig.1.5 A). This sRNA is completely 
independent from the transcription of dapB and has a different outcome associated, since the dapB gene 
is essential for the biosynthesis of lysine and DapZ causes a translational repression of genes that encode 
major ABC transporters [50]. The cpxP mRNA belonging to the Cpx regulon of Salmonella is a perfect 
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example of type II sRNAs, due to its associated dual output. CpxQ sRNA is the first processed 3’ UTR 
multi-target regulator to be known. It overlaps the 3’ UTR of the cpxP mRNA and both share the same 
promoter, which makes CpxQ sRNA dependent of cpxP transcription (Fig. 1.5. B). After transcription 
of the parental mRNA, CpxQ is generated through processing in 3’ region of the coding sequence by 
RNase E cleavage, a few nucleotides downstream of cpxP stop codon (Fig. 1.5. B) [48]. Although CpxP 
protein and CpxQ noncoding RNA act in the same pathway, they perform different but complementary 
functions since CpxP is a periplasmic protein involved in envelope stress [51] and CpxQ sRNA is a 
cytoplasmic effector that repress mRNAs from several envelope proteins [48]. 
 
Figure 1.5 sRNAs from bacterial 3’ UTRs. Transcription of sRNAS from bacterial 3’ UTRs can occur by its own promoter 
(type I) (A) or through internal processing of the associated mRNA by RNase cleavage (type II) (B). The sRNA resulting from 
processing in the mRNA 3’ region carry a 5’ monophosphate end, which is a sensor domain of RNase E. In both cases Hfq 
protein is involved in the stabilization of the sRNA and mediates its interaction with their targets. Furthermore, Hfq is also 
involved in the internal processing since it can form a complex with RNase E and direct it to the 3’ end of mRNAs. The grey 
arrows represent the promoters. Adapted from [48]. 
1.3.4 Regulatory sRNAs of protein activity 
The majority of the already characterized sRNAs act through base pairing with their target transcripts. 
Nevertheless, a small number of sRNAs capable of binding to proteins and modify directly their 
activities have also been identified. These RNAs, which include the E. coli 6S RNA and the CsrB family 
of sRNAs, exert their function by mimicking the structures of other nucleic acids [19].  
A few years ago, the 6S RNA was found to bind to the active site of a RNA polymerase holoenzyme 
comprising a σ70 subunit (housekeeping form of RNA polymerase). Consequently, it inhibits the 
expression of certain promoters and increases the association with alternative stress sigma factors when 
the transition between exponential and stationary phase of growth occurs. Moreover, this RNA has a 
remarkable accumulation during the late stationary phase which has been associated with the 
sequestration of the majority of σ70 holoenzyme [52]. Later studies have revealed that the structure of 
6S RNA governs the σ70 holoenzyme sequestration with the double-stranded RNA hairpin containing a 
critical central bulge mimicking the promoter open complex [53]. 
The E. coli carbon storage regulator protein (CsrA) was identified as a RNA-binding protein, as well as 



















the entry into the stationary phase [54]. CsrA homodimers bind to GGA motifs in stem-loops of a RNA 
hairpin located in the 5’ UTR of their mRNA targets. Therefore, the stability and/or translation of the 
mRNA will be affected (reviewed in [19]). The intracellular levels of this protein are mostly negatively 
regulated by two sRNAs enclosing multiple CsrA binding sites, CsrB and CsrC. When the levels of 
these RNAs increase they interact and sequester the RNA-binding protein. Opposite to the regulation of 
the housekeeping form of RNA polymerase, the CsrB and CsrC antagonize CsrA protein, precluding 
the binding to the target mRNAs (reviewed in [54]). 
1.4 Cell advantages of regulating with sRNAs 
Regulatory RNAs, such as sRNAs, appear to be widely distributed in the Bacteria domain. Moreover, 
they are also present in several vital functions performing a regulatory role in diverse environmental 
conditions and overcoming other regulators, which include protein transcription factors. 
As already mentioned, bacteria are often present in hostile environments with a high rate of changing 
conditions and often exposed to external stimuli. Thus, it is beneficial for cells to store energy to be 
further used in growth and/or maintenance. 
sRNAs are single-stranded RNA molecules with a medium size ranging around a few hundreds of base 
pairs. Due to the fact that they are shorter in size than the majority of mRNAs they provide a reduced 
metabolic cost for the cell and faster synthesis when compared to protein transcription factors. In 
addition, they do not require translation minimizing the metabolic cost (reviewed in [20]). Furthermore, 
sRNAs act at the posttranscriptional level of regulation and with these advantages it is possible to 
conclude that not only the response to the unforeseen stress conditions will be faster but also the recovery 
will be more rapid after the removal of the external stimulus. In both cases, the faster regulation confers 
a selective advantage [55]. 
The capacity of a unique sRNA to be transcribed under different conditions together with the irreversible 
regulatory effects achieved by the ability of some sRNAs to direct the cleavage of their targets are also 
important advantages of sRNAs [14]. 
1.5 Burkholderia cepacia complex (Bcc) – overview 
During the late 1940’s, Walter Burkholder [56] studied the phytopathogenic agent responsible for the 
soft onion rot bulbs, a disease known as “sour skin”. During his investigation, the bacterial species 
Pseudomonas cepacia was isolated and described for the first time [56].  
In 1992, a molecular taxonomical analysis of the genus Pseudomonas based on the 16S rRNA 
sequences, DNA-DNA homology, cellular lipid and fatty acid composition and also in phenotypic 
characteristics was performed. This analysis resulted in the proposal of a new genus named Burkholderia 
and, consequently, some species previously inserted in the genus Pseudomonas, particularly 
Pseudomonas cepacia, were transferred to the new genus. Pseudomonas cepacia was further renamed 
as Burkholderia cepacia [57]. The Burkholderia genus is phylogenetically diverse. By November 2016, 
this genus included approximately 105 species [58] that are widely distributed in ecological niches [59]. 
Subsequently, Burkholderia species were shown to present several biotechnological properties such as 
bioremediation and biocontrol/biopesticides agents. These applications in biotechnology are due to their 
ability to i) degrade natural and man-made complex aromatic pollutants in water and soils, ii) produce 
antifungal compounds, iii) fix atmospheric nitrogen and iv) promote growth of plants and crop 
production (reviewed in [59]). However, Burkholderia species have emerged in the 1980s as important 
pathogens to both humans and animals, in particular to cystic fibrosis (CF) patients [60]. 
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The polyphasic taxonomic study performed by Vandamme et al. [61] with Burkholderia cepacia isolates 
from CF patients demonstrated that these bacteria are grouped into five distinct species, then designated 
as genomovars (I-V), together forming a group of closely related species denominated Burkholderia 
cepacia complex (Bcc). 
Bcc bacteria display a diverse nutrition, since they are able to use a broad range of simple and complex 
molecules as carbon sources, including xenobiotics (reviewed in [59]). 
The genome of Bcc species has some interesting properties: i) its large size, which is correlated with 
their high functional versatility [62], and ii) its organization in three replicons and, in some cases, 
plasmids. Recent studies performed by Agnoli et al. [63] demonstrated that these microorganisms are 
able to tolerate the deletion of the third chromosome. These findings suggest that the third replicon could 
be a plasmid. Currently, this cluster is known to comprise 20 validated and close related species (Table 
1; [58,64]), exhibiting a high level of 16S rRNA (over 98%) and recA (94%-95%) gene sequence 
similarity but a moderate degree of DNA-DNA hybridization (30%-60%) [65]. It has also been 
demonstrated that different Bcc species share whole-genome average nucleotide identity (ANI) with 
values ranging from 85.04% and 89.92% [66]. 
Table 1.1 Burkholderia cepacia complex (Bcc) species, their main sources and biotechnological applications according 
to the List of Prokaryotic Names with Standing in Nomenclature (LPSN) [58]. CF: Cystic Fibrosis. 
 
In more recent years, a new approach known as multilocus sequence typing (MLST) has gained notoriety 
among bacterial typing methods [80]. MLST uses a set of seven genes encoding proteins with 
housekeeping functions and discriminates strains based on the comparison of the nucleotide sequences 
Bcc species Main sources and biotechnological applications References 
B. cepacia 
Main pathogen in Portuguese CF population [67]; present in the environment; 
used has bioremediation and biocontrol agent 
[57] 
B. vietnamiensis 
Infections in Humans (CF and non-CF); present in the rhizosphere; used has 
bioremediation and biocontrol agent;  
[68] 
B. multivorans 
Infections in Humans (CF and non-CF, being one of the main CF pathogens in 
European CF centers [69]); present in the rhizosphere  
[61] 
B. pyrrocinia Infections in Humans (CF and non-CF); used has biocontrol agent [70] 
B. stabilis Isolated from CF and non-CF patients [71] 
B. ubonensis Infections in non CF patients (isolated from nosocomial infections) [72] 
B. ambifaria 
Infections in Humans (CF and non-CF); major bacterium present in the 
rhizosphere; used has biocontrol agent;  
[73] 
B. anthina Infections in CF patients and animals; present in soils [74] 
B. cenocepacia 
Infections in Humans (CF and non-CF, being one of the main CF pathogens); 
present in the rhizosphere; used has biocontrol agent 
[75] 
B. dolosa 
Causes mostly infections in CF patients, but one environmental strain has been 
described 
[76] 
B. arboris Infections in Humans (CF and non-CF); present in the environment  [77] 
B. diffusa Infections in Humans (CF and non-CF); present in the environment and soils [77] 
B. latens  Infections in CF patients [77] 
B. metallica Infections in CF patients [77] 
B. seminalis Infections in Humans (CF and non-CF); present in the environment [77] 
B. contaminans 
Infections in Humans (main pathogen among Portuguese CF population [67] 
and animals  
[66] 
B. lata Infections in Humans (CF and non-CF); highly present in soils [66] 
B. pseudomultivorans Present in Humans and the environment [78] 
B. stagnalis Present in soils and in Humans respiratory tract  [79] 
B. territorii Present in the environment, especially in groundwater   [79] 
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of the gene set. Nowadays, it is the standard technique used to differentiate Bcc isolates since it shows 
a high correlation with other methods and a high discriminatory power [66]. The primers and other 
information on Bcc MLST can be accessed at http://www.pubmlst.org/bcc/.  
1.5.1 Bcc species as opportunistic pathogens in Humans 
The first significant descriptions of Bcc infections in patients with CF were performed three decades 
ago by Isles et al. [60] and Tablan [81]. CF is the most common autosomal recessive monogenic disease 
among the Caucasian population. It has an estimated frequency of 1 to 8,000 live births in Portugal [82]. 
Some Bcc bacteria are highly transmissible among CF patients, particularly by social contacts. Several 
strains belonging to B. multivorans, B. cenocepacia (particularly lineage ET12) and B. dolosa species 
have been reported to cause outbreaks in CF centers worldwide [83]. During the last decade, the Bcc 
prevalence in CF patients had a significant decrease, representing about 3.5% of CF infected patients 
[84]. Although representing a small fraction, Bcc infections are the most feared and through the years 
have gained special attention from the patients, medical and scientific communities due to their 
unpredictable clinical outcome. 
CF is the result of mutations occurring in a single gene present at the long arm of chromosome 7, which 
encodes a 1,480 aa polypeptide known as Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) [85]. The CFTR protein functions mainly as a 3’,5’- cyclic adenosine monophosphate (cAMP)-
dependent chloride channel of low conductance at the apical membranes of epithelial cells that are 
present in a variety of organs such as sweat glands, pancreas, liver and respiratory and reproductive 
tracts [86]. However, this protein can also regulate the function of sodium channels [87]. 1,800 
mutations with different outcomes in the CFTR protein have been identified as potentially CF-causing 
[88]. Independently of the molecular mechanism by which the mutation disrupts the normal protein 
synthesis or function, an atypical transepithelial ion transport of chloride and water occurs. Although 
several organs are affected, the variations affecting the respiratory tract are the main cause of 
morbimortality in CF patients, since this defect allows the deposition of thickened mucus and prevents 
its removal from airway surfaces [89]. Therefore, the conditions generated inside the lungs predispose 
to the establishment of bacteria, leading to chronic pulmonary infections [89,90] mostly caused by 
Staphylococcus aureus in young individuals and by Pseudomonas aeruginosa in adults [91,92]. The 
majority of Bcc infected CF patients undergo a reduction of the pulmonary function caused by the 
chronic infection and exacerbation events. Approximately 20% of these patients develop in their lifetime 
a rapid evolving clinical state known as “cepacia syndrome”. This syndrome has not yet been observed 
for other CF pathogens and it is characterized by high fevers, necrotizing pneumonia and septicaemia, 
which ultimately results in the patient early death [60]. 
Bcc infections are also notably difficult to treat and the strategies applied rarely result in eradication of 
the bacteria upon colonization. One of the major contributors to this problem is their intrinsic resistance 
to the majority of clinically available antimicrobials, which include aminoglycosides, quinolones, 
polymyxins and β-lactams [93]. Moreover, these microorganisms have several efflux pumps that can 
withdraw antibiotics from the cell and have the ability to modify the cell envelope leading to a reduced 
permeability of the membrane to antibiotics (reviewed in [94]). 
Bcc bacterial infections have also emerged in patients with other pathologies such as chronic 
granulomatous disease (CGD) [95] and immunocompromised (patients with cancer and HIV) [96,97]. 
Similarly, to CF, CGD is also an hereditary disease, although with a much lower incidence than CF, 
where bacterial infections caused by Bcc species and their consequences represent the second most 
common cause of death [95]. This disease is considered to be a primary immune disorder since it is 
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caused by mutations in the subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase complex belonging to the phagocytes. These mutations lead to a defective production of reactive 
oxygen species (ROS) by the phagocytes and therefore they are unable to kill bacteria through oxidative 
processes [95]. 
In addition to spread by social contact among CF patients, several outbreaks of bacteraemia have been 
reported among hospitalized non-CF patients such as individuals having chronic hemodialysis, diabetes 
mellitus, congestive heart failure and malignancy, mainly caused by B. cenocepacia, B. multivorans 
[98,99] and B. contaminans [100,101]. Therefore, Bcc species are now recognized as emergent 
nosocomial pathogens [69,97]. 
1.5.2 Major virulence factors of the Bcc 
In order to enter in their host and reach the blood stream, as well as to proliferate inside eukaryotic cells, 
Bcc bacteria produce a wide variety of virulence factors, being the best characterized those produced by 
the B. cenocepacia ET12 lineage representative J2315 (reviewed in [59]). 
The lipopolysaccharide (LPS) is one of the fundamental virulence factors in Gram-negative bacteria. 
The particular composition of the core oligosaccharide has been reported as implicated in the resistance 
of Bcc bacteria to cationic antimicrobial peptides and polymyxins [102,103]. 
Only a few polysaccharides synthesized by prokaryotes can be excreted, which are known as 
exopolysaccharides – EPS [104]. Among Bcc bacteria, production of EPS is very fluctuating, however 
some clinical and environmental isolates are known to produce a particular EPS – Cepacian [105]. 
Several studies have associated Cepacian production with the persistence of infection by Bcc bacteria, 
defective phagocytosis process of bacteria by neutrophils and an inhibition of neutrophil chemotaxis 
and ROS production [106,107]. Studies performed by Cunha et al. [108] have demonstrated that 
Cepacian also plays an important role in the formation and establishment of biofilms. 
Bacteria have a remarkable capacity to form communities known as biofilms, in order to be protected 
from environmental factors and host-defence mediators so they can establish and persist in the host 
airways [109]. Caraher et al. [110] have demonstrated an enhanced in vitro antibiotic resistance 
(particularly to ceftazidime and ciprofloxacin) upon the formation of biofilms by Bcc bacteria, 
presumably due to a decrease of the bacterial surface exposed to the antibiotics. The resistance to 
multiple antibiotics by Bcc strains constitutes also an important virulent characteristic and has already 
been addressed in section 1.5.1. 
In addition to the generation of communities Bcc also possess the quorum-sensing systems (QS). QS is 
density-dependent and supports the prompt adaptation of bacteria to the environment. The CepIR was 
the first QS system identified in a Bcc strain [111] and it is responsible for the regulation of toxins, 
lipases, proteases, iron-chelating siderophores, swarming motility and biofilm production (reviewed in 
[112]). 
The acquisition of clusters of genes through horizontal gene transfer by Bcc strains (genomic islands) is 
of extreme importance since these islands encode virulence and metabolism associated genes. On the 
other hand, these genes promote both the survival and pathogenesis of Bcc bacteria in the CF respiratory 
epithelium and, consequently, the development of an epidemic lineage [113]. 
Moreover, these bacteria also express a particular type of fimbriae, the cable pili, with adhesins 
associated and flagella. Both the cable pili and the flagella help in bacterial adhesion and entry into the 
respiratory epithelium of host cells [114]. 
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Specialized secretion systems such as type III and type VI also have determining roles in Bcc species, 
regarding to bacterial intracellular survival and replication. These complex structures inject bacterial 
molecules into the host cytoplasm, triggering host-signalling pathways and leading to the establishment 
of a bacterial intracellular niche [115,116]. 
1.5.3 Identification of novel Bcc virulence factors 
In order to identify genes involved in Bcc virulence, researchers from iBB (Institute for Bioengineering 
and Biosciences) have prepared two mutant libraries by plasposon mutagenesis from strains B. 
contaminans IST408 and B. cenocepacia J2315. 
The strategy used to identify genes involved in virulence was based on the identification of mutants with 
attenuated virulence towards the nematode Caenorhabditis elegans. Several mutants were identified and 
the sequencing of the interrupted genes allowed the identification in B. contaminans of a gene encoding 
a protein involved in RNA-RNA interactions – the hfq gene. Subsequent research work led to the 
identification of a second gene, named hfq2, within the genome of all Bcc strains sequenced. This is 
extremely rare among prokaryotes, which usually harbour one hfq gene in their genome. 
Bcc Hfq proteins have different sizes, since the Hfq has 79 aa residues and the Hfq2 has 188 aa residues 
[117]. Experiments with the clinical isolate B. cenocepacia J2315 and respective mutants in the Hfq 
encoding gene showed that the hfq mutant had an increased susceptibility to conditions mimicking the 
lung environment of a CF patient. Furthermore, infection experiments with hfq and hfq2 mutants 
demonstrated that both genes are required for full pathogenesis and virulence in the nematode C. elegans 
[117,118]. 
The iBB research team also identified another attenuated mutant found to have a single plasposon 
insertion in a 555 bp intergenic region of B. cenocepacia J2315 chromosome 1, upstream of the start 
codon of BCAL2958 gene, which encodes an outer membrane protein of the OmpA family, and 
downstream of the 5’ UTR of BCAL2957 gene, which in turn encodes a DNA gyrase subunit A enzyme. 
Bioinformatics analysis and RT-PCR experiments revealed the presence of a putative sRNA and non-
annotated ORF in the region where the plasposon was inserted. In this context, the aim of this work is 
the functional characterization of the identified putative sRNA and ORF, later found to be widely 
conserved among the Burkholderia genus. To achieve this goal, molecular techniques were adopted in 
order to characterize the sRNA and the hypothetical ORF. In addition, stress, mobility and virulence 
assays in the nematode C. elegans, as well as an extensive bioinformatics analysis were performed. 
This study presents a contribute to better understanding of the regulatory mechanisms played by sRNAs 
in the expression of virulence determinants by Bcc bacteria. Despite the results obtained are somehow 
limited they contribute to a better understanding of Bcc biology, which is of central importance for the 
future development of novel and more accurate therapeutic strategies against the severe infections 





2. MATERIALS AND METHODS 
2.1 Bacterial strains, plasmids, nematode and culture conditions 
All bacterial strains, plasmids and the nematode used in this work are listed in Table 2.1 B. cenocepacia 
and E. coli strains were maintained in Pseudomonas Isolation Agar (PIA; Benton Dickinson) and 
Lennox Broth (LB; Pronadisa), respectively, with 2% (w/v) agar (Iberagar). Unless otherwise stated, B. 
cenocepacia and E. coli strains were cultured on solid media and incubated at 37 ºC for 24 h. In order 
to maintain selective pressure, when required, solid growth media was supplemented with adequate 
antibiotics. Antibiotics were used as follows: 300 µg/mL chloramphenicol or 600 µg/mL trimethoprim 
for Burkholderia strains and 150 µg/mL ampicillin, 50 µg/mL kanamycin or 100 µg/mL trimethoprim 
for E. coli strains. 







E. coli strains   
E. coli α-DH5 
 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Invitrogen 
E. coli HB101  
 
F–, thi-1, hsdS20 (rB–, mB–), supE44, recA13, ara-14, leuB6, proA2, 
lacY1, galK2, rpsL20 (strr), xyl-5, mtl-1 
Promega 
E. coli OP50 Uracil auxotroph strain for C. elegans feeding [119] 
   
Burkholderia strains   
B. cenocepacia J2315 
Clinical isolate from a CF pacient, Edinburgh (UK). Reference strain 
from ET12 lineage  
  
[98] 
B. cenocepacia J2315 
(pMLS7)  
B. cenocepacia J2315 transformed with pMLS7 This study 
B. cenocepacia J2315 
(pMya2) 
B. cenocepacia J2315 transformed with pMya2 This study 
B. cenocepacia SJ2  
Mutant derived from B. cenocepacia J2315 by random plasposon 
mutagenesis with pTnMod-OCm 
This study 
   
Plasmids   
pUC19 Clonning vector, lacZ α-peptide, Ampr [120] 
pRK2013 Mobilizing vector, ColEI tra(RK2)+; Kmr [121] 
pMLS7 Clonning vector, pBBR1 ori, mob, Tpr [122] 
pMya2 
pMLS7 containing the 502 bp fragment with the mavA sequence and 
promoter region from B. cenocepacia J2315  
This study 
   
Nematode    
C. elegans mutant strain 
DH26 
C. elegans with a temperature-sensitive mutation, rendering worms 
sterile at 25 ºC 
[123] 
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Liquid cultures were performed at 37 ºC overnight with orbital agitation (250 rpm) in 4 mL of LB liquid 
medium supplemented with the appropriate antibiotics. Bacterial cultivation for growth kinetics 
characterization was carried out in 25 mL of LB or M9 [1X M9 salts (374 mM NH4Cl, 441 mM KH2PO4 
and 448 mM Na2HPO4·7H2O), 22.2 mM Glucose, 1 mM MgSO4 and 8.6 mM NaCl] medium, inoculated 
at an initial optical density of 0.1 measured at 640 nm (OD640 nm), and incubated at 37 ºC with orbital 
agitation. Bacterial growth was followed for 24 h in LB medium or for 72 h in M9 medium through 
measurements of the culture OD640 nm. The specific growth rate was calculated for LB medium, using 
the exponential equation from GraphPad Prism version 6.01 for Windows (GraphPad Software, La Jolla, 
California USA). The results herein presented are mean values from two independent experiments for 
the growth curve in LB and from three independent experiments for the growth curve in M9 medium.  
When not in use, bacterial strains were maintained at -70 ºC in 40% (v/v) glycerol. 
2.2 Molecular biology techniques  
2.2.1 Extraction and purification of genomic and plasmid DNA 
Plasmid DNA was extracted from E. coli cultures grown overnight in LB medium supplemented with 
the adequate antibiotics, using the NZYMiniprep kit (NZYTech) in accordance to the manufacturer’s 
instructions. Total genomic DNA from overnight liquid cultures of B. cenocepacia J2315 was extracted 
using the High Pure PCR Template Preparation kit (Roche), according to the manufacturer’s 
instructions. The concentrations of both plasmid and genomic DNA were estimated 
spectrophotometrically by measuring samples absorbance at 260 nm with a ND-1000 spectrophotometer 
(NanoDrop). When necessary, DNA fragments were purified from agarose gels with NucleoSpin® Gel 
and PCR Clean-up (Macherey-Nagel), after gel electrophoresis with 1X TAE buffer (40 mM Tris.base, 
20 mM Acetic acid and 1 mM EDTA) at 4 V/cm [124] and subsequent gel staining with GelRedTM 
Nucleic Acid Gel Stain (Biotium), according to the manufacturer’s instructions. DNA was visualized 
with a UV transilluminator (Bio-Rad). 
2.2.2 Construction of a plasmid expressing the MavA sRNA 
In order to analyse the MavA sRNA function in B. cenocepacia J2315, the B. cenocepacia J2315 MavA 
putative encoding sequence was amplified with the primers Hip_UP (5’ 
TTGGATCCATGAACGCGAGCT 3’) and P8D4_3’ (5’ TTGTCGACGAATTCGCCTTCC 3’), 
retrieving a 502 bp fragment.  This fragment was first ligated to the BamHI/ SalI restriction sites of 
pUC19 and then to the BamHI/HindIII restriction sites of the constitutive expression vector pMLS7 (B. 
cepacia promoter PS7) [122], with T4 DNA Ligase (Fermentas). The resulting construction, named 
pMya2, was introduced into E. coli α-DH5 cells by heat-shock transformation and into B. cenocepacia 
J2315 by triparental mating.  
2.2.3 Insertion of foreign DNA in bacterial cells 
2.2.3.1 Heat-shock transformation of E. coli cells 
E. coli α-DH5 cells were prepared according to Sambrook and Russell [124]. Briefly, 100 mL of LB 
liquid medium were inoculated to a final OD640 nm of 0.1 from overnight liquid cultures (at 37 ºC) and 
maintained under the same conditions until the culture reached the mid-log phase (OD640 nm ≈ 0.6–0.8). 
The liquid culture was then centrifuged (2,700 x g, 5 min, 4 ºC) and the cell pellet was carefully 
resuspended in 100 mL of 0.1 M MgCl2. After a second centrifugation (1000 x g, 5 min, 4 ºC), the cell 
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pellet was carefully resuspended in 100 mL of 0.1 M CaCl2, incubated on ice for 30 min and subjected 
to another centrifugation step under the same conditions. The resulting cell pellets were resuspended in 
22 mL of 0.1 M CaCl2. 3.5 mL of 86% (v/v) glycerol was added and aliquots were frozen at -70 ºC or 
immediately used for transformation. 
The competent E. coli cells were transformed by heat-shock transformation. Briefly, 150 μL of 
competent cells and 50 μL of TCM salts (10 mM CaCl2, 10 mM MgCl2 and 10 mM Tris, to a final pH 
of 7.5) were added to the 1.5 mL eppendorf containing the plasmid DNA, followed by incubation on ice 
for 30 min. The cells were then heat-pulsed at 42 ºC for 3 min and transferred to ice for 5 min. Finally, 
cells were incubated in liquid LB medium for 1 h and then plated in selective medium [124,125]. 
2.2.3.2 Triparental mating of B. cenocepacia cells 
Triparental conjugation experiment was adapted from Engledow et al. [126] and Dubarry et al. [127]. 
The E. coli donors [E. coli α-DH5 (pMLS7) and E. coli α-DH5 (pMya2)] and helper strain (E. coli 
HB101 carrying pRK2013), as well as the recipient strain (B. cenocepacia J2315) were grown overnight, 
separately, in liquid LB medium supplemented with the appropriate antibiotics. The overnight cultures 
were then diluted to a final OD640 nm of 0.1 in 25 mL of fresh LB medium, supplemented with antibiotics, 
and were grown under the same conditions to an OD640 nm ≈ 0.6. Cells from 0.4 mL of the recipient strain 
cultures and of 0.2 mL of the helper and donor strains cultures were separately harvested by 
centrifugation, washed and resuspended with sterile 0.9% (w/v) NaCl. Then, the three bacterial cultures 
(recipient, helper and donor strain) were mixed together and harvested at low speed centrifugation for 5 
min. The resulting pellet was resuspended in 100 µL of 0.9% (w/v) NaCl and spot-inoculated on the 
surface of a sterile 47 mm diameter filter disk (Supor®, 0.2 µm pore size, GelmanSciences), previously 
placed onto the surface of a LB agar plate. After 16 h of incubation at 30 ºC, the bacterial layer formed 
in the surface of the filter was washed and resuspended in 1 mL of sterile 0.9% (w/v) NaCl. Serial 
dilutions were prepared and 100 µL of each dilution were plated on appropriate selective medium (PIA 
agar plates supplemented with 600 µg/mL of trimethoprim) for positive selection of transconjugants. 
2.2.4 DNA sequence analysis 
Nucleotide sequences were retrieved from National Centre for Biotechnology Information (NCBI) 
website (http://www.ncbi.nlm.nih.gov/) and the Burkholderia Genome Database [128]. DNA 
sequencing was performed by Operon MWG Eurofins (Germany) as a paid service. The nucleotide 
sequences retrieved from Operon MWG Eurofins were analysed with VecScreen 
(http://www.ncbi.nlm.nih.gov/VecScreen/VecScreen.htm) in order to identify and eliminate vector 
contamination. BLASTN 2.5.1 algorithm [129] was also used to compare the obtained sequences with 
those available at NCBI. Additionally, multiple alignments were performed using the MUSCLE tool 
(http://www.ebi.ac.uk/Tools/msa/muscle/) [130]. The intergenic region studied in this work was 
analysed for the potential presence of encoded proteins with the ORF Finder tool 
(https://www.ncbi.nlm.nih.gov/orffinder/). 
2.2.5 Extraction and purification of total RNA 
Cells from liquid cultures of B. cenocepacia J2315 strain and its derivative mutant SJ2 were harvested 
by centrifugation (5,500 x g, 3 min, 4 ºC) at mid-log phase (6 h of incubation), mixed with RNA Later 
Solution (Ambion) and frozen at -20 ºC. Total RNA was extracted from these samples using the Quick-
RNATM MiniPrep (Zymo Research), according to the manufacturer’s instructions. DNase I treatment 
was performed in order to remove trace amounts of contaminating DNA. RNA concentration was 
16 
estimated by a ND 1000 spectrophotometer (Nanodrop). Samples with ratios A260 nm/A280 nm and A260 
nm/A230 nm below 1.9 were not considered. RNA quality was evaluated by electrophoresis of 1 µg of RNA 
samples, mixed with Gel Loading Buffer II (Ambion) and incubated at 95 ºC for 3-5 min, in denaturing 
gels (7 M urea - 10% (v/v) polyacrylamide) with 1X TBE buffer (89 mM Tris.base, 89 mM Boric acid 
and 2 mM EDTA) at 200 V. 
After electrophoresis, the acrylamide gel was stained for 15 min with SYBR® Gold Nucleic Acid Gel 
Stain (Thermo Fischer Scientific), according to the manufacturer’s instructions, and exposed to short 
wave UV light in a transilluminator (Bio-Rad). 
2.2.6 Reverse transcription-polymerase chain reaction (RT-PCR) 
The total RNA obtained from B. cenocepacia J2315 and its derivative mutant SJ2 cells harvested at mid-
log phase (6 h of incubation), was extracted as described in section 2.2.5. In order to completely remove 
any trace amounts of contaminating DNA, total RNA was subjected to two DNase (RiboPure Bacteria 
kit, Life Technologies) treatments of 60 min each. Treated RNA was precipitated overnight at -20 ºC 
with 2.5 volumes of cold 100% (v/v) ethanol, 0.5 M ammonium acetate and 100 µg/mL glycogen. Next, 
the mixture was centrifuged (16,000 x g, 30 min, 4 ºC) and the RNA was washed with 70% (v/v) ethanol, 
air dried and re-dissolved in water. 
Complementary DNA (cDNA) was generated with the NZY First-Strand cDNA Synthesis kit 
(NZYtech), using 250 ng of purified RNA from each strain. All the amplifications performed were done 
with Phusion DNA polymerase (Thermo Scientific). In order to confirm the transcription of MavA 
sRNA in both strains, the cDNA previously obtained was amplified with the primers LW_MavA (5’ 
TTCTAGAGTGTTTCACGCACACGAG 3’) and RACE 3 (5’ AAAATCCTCCCCACCCCAAG 3’). 
The transcription of the OmpA protein was confirmed with the primers BCAL2958-UP (5’ 
TTGGATCCATGAATAAACTTT 3’) and BCAL2958-LW (5’ AAAAGCTTGTTTGCCGGAAC 3’), 
whereas the transcription of the putative ORF was evaluated by amplification with the primers RACE 1 
(5’ AGTTGAAGCGATCTTGGGGT 3’) and Hip_UP (described in section 2.2.2). The initial samples 
of total RNA were used as negative controls and a sample of genomic DNA from B. cenocepacia J2315 
was used as a positive control. The samples obtained in the Polymerase Chain Reactions (PCR) were 
separated in a 2% (w/v) agarose gel electrophoresis.  
2.2.7 Rapid amplification of cDNA ends (RACE) 
RNA purified from B. cenocepacia J2315 at mid-log phase (6 h of incubation) was used for 
amplification of the cDNA ends corresponding to MavA sRNA, which was performed using the 
FirstChoice® RLM-RACE kit (Ambion), according to the manufacturer’s instructions. For 5’ RACE, 
total RNA was treated in order to preserve a 5’- monophosphate, enabling the ligation of the 45 bp 5’ 
RACE Adapter (5’ GCUGAUGGCGAUGAAUGAACACUGCGUUUGCUGGCUUUGAUGAAA 
3’), and then, reverse transcribed. The tailed cDNA was nest amplified first with 5’ RACE Outer primer 
(5’ GCTGATGGCGATGAATGAACACTG 3’) and a 5’ RACE gene specific outer primer (Int3_UP: 
5’ CTCTAAAAGTTACGGCAGGC 3’), followed by amplification with 5’ RACE Inner primer (5’ 
CGCGGATCCGAACACTGCGTTTGCTGGCTTTGATG 3’) and a 5’ RACE gene specific inner 
primer (RACE 1, described in the above section). Previously to 3’ RACE, total RNA was 3’ end poly(A) 
tailed using a Poly(A) polymerase I (Ambion) and then reverse transcribed with 3’ RACE Adapter (5  
GCGAGCACAGAATTAATACGACTCACTATAGGT12VN 3’). After these initial steps, tailed 
cDNA was amplified with 3’ RACE Outer primer (5  GCGAGCACAGAATTAATACGACT 3’) and a 
3’ RACE gene specific outer primer (RACE 2: 5’ GCCATATCGTTCCCTTCCTA 3’). The resulting 
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products were independently purified through 2% (w/v) agarose gel electrophoresis and blunt-end 
cloned into the HincII site of pUC19, followed by E. coli α-DH5 heat-shock transformation, for 
sequencing.  
2.2.8 Analysis of total soluble proteins by Tricine-SDS-PAGE  
All B. cenocepacia strains under study were inoculated in 4 mL of LB and M9 media with the 
appropriated antibiotics at an initial OD640 nm of 0.1 and incubated at 37 ºC with orbital agitation. After 
8 h of incubation in LB medium and 24 or 48 h in M9 medium, 1 mL of the cultures at OD640 nm 0.6 were 
collected and the resulting pellet was resuspended in 40 μL of sample buffer solution [10% (v/v) 
Glycerol, 4% (w/v) Sodium Dodecyl Sulphate (SDS), 0.2% (w/v) Bromophenol blue, 2% (w/v) 
Mercaptoethanol, 1.2% (w/v) Tris (pH 6.8)]. Samples were incubated at 37 ºC for 1 h and loaded in a 
discontinuous tricine gel system, allowing proteins to be concentrated [stacking gel, 4% (v/v)] and 
separated according to their relative molecular mass [running gel, 15% (v/v)] [131]. 
Protein electrophoresis was performed at room temperature using 1X anode (0.1 M Tris, 22.5 mM HCl, 
pH≈ 8.9) and cathode (0.1 M Tris, 0.1 M Tricine, 34.7 mM SDS, pH≈ 8.25] buffers. Voltage was kept 
at 30 V until samples enter the running gel, then the voltage was increased to 150 V, 80 mA and 10 W, 
as described by Schägger [131]. Proteins were visualized after gel staining with previously boiled 
Coomassie blue staining solution [0.2% (w/v) Coomassie blue R-250, 10% (v/v) Acetic acid, 47.5% 
(v/v) Ethanol] for 30 min. After washing with deionized water, the gel was placed into a previously 
boiled destaining solution [10% (v/v) Acetic acid, 26.3% (v/v) Ethanol], for 15-60 min. 
2.2.9 Western blot experiments  
Western blot analysis against OmpA-like protein was carried out using B. cenocepacia J2315 and B. 
cenocepacia SJ2 cells extracts harvested by centrifugation (5,500 x g, 3 min, room temperature) at mid-
log phase (6 h of incubation). The resulting cell pellet was resuspended in 40 μL of the sample buffer 
solution [20% (v/v) Glycerol, 4% (w/v) SDS, 0.2% (w/v) Bromophenol blue, 3% (w/v) 1,4-
Dithiothreitol (DTT), 1.2% (w/v) Tris (pH 6.8)]. Samples were incubated at 100 ºC for 5 min and loaded 
in a 12.5% (v/v) SDS-PAGE [132]. Total protein electrophoresis was carried out at room temperature 
using 1X running buffer (0.25 M Tris.base, 1.92 M Glycine, 34.7 mM SDS) at a constant voltage of 150 
V, 80 mA and 10 W. 
After electrophoresis, gel, the nitrocellulose (NC) membrane (BiotraceTM, NT, Pall Corporation) and 
3MM Whatmann® filter papers were immersed in Bjerrum and Schafer-Nielsen buffer [0.58% (w/v) 
Tris, 0.29% (v/v) Glycine, 20% (v/v) Methanol, 0.04% (w/v) SDS] and the system was assembled. Total 
proteins were electrotransfered to the membrane at 15 V, 120 mA for 50 min in a semi-dry 
electrophoretic transfer unit (Trans-Blot® SD, Bio-Rad). The membrane was blocked by incubation with 
5 % (w/v) skimmed milk (DIFCO) in 1X Phosphate Buffered Saline solution (PBS; 140 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4, pH 7.4), overnight at 4 °C with agitation. Afterwards, 
the membrane was washed three times with 1X PBS containing 0.05% Tween® 20 and probed with the 
primary Goat antibody anti-BCAL2958 (1:3,000 dilution, SICGEN), developed by Sousa et al. [133], 
for 2 h at room temperature. The membrane was then incubated with the secondary antibody HRP—
conjugated Mouse anti-Goat IgG (1:10,000 dilution, Santa Cruz Biotechnology), for 1 h at room 
temperature. Lastly, the membrane was briefly incubated with the peroxidase substrate ECL (Sigma) 
and the chemiluminescent signals were detected with the device FUSION Solo (Vilber Lourmat). 
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2.3 Nematode killing assays  
2.3.1 Maintenance of C. elegans and egg preparation 
C. elegans worms were cultured at 20 ºC on nematode growth medium I [NGM I agar plates contained 
0.3% (w/v) NaCl, 0.25% (w/v) Tryptone and 1.7% (w/v) Agar. This medium was supplemented with 
0.05 mM Nystatin and 25 mM KPO4 buffer (796 mM KH2PO4, 204 mM K2HPO4. pH 6.0), 1 mM CaCl2, 
1 mM MgSO4, 0.02 mM Uracil and 0.01 mM Cholesterol] [134], previously inoculated with 100 L of 
a fresh overnight culture of E. coli OP50 and incubated at 37 ºC overnight. Every week, nematodes were 
maintained in culture by cutting a piece of agar covered with E. coli and C. elegans for a fresh new E. 
coli plate. 
C. elegans eggs were collected by rinsing four times the plate containing both worms and eggs with 1 
mL of sterile deionized water and the suspension was divided in three tubes. 500 μL of hypochlorite 
solution (4% (v/v) NaClO and 6% (w/v) NaOH) were added to each tube and vortexed for 8-10 min. 
Afterwards, this suspension was centrifuged (700 x g, 1 min, room temperature) and the supernatant 
was carefully discarded. The pellet was washed with 1 mL of sterile bidestilled water, centrifuged in the 
same conditions above mentioned and then, resuspended in 100-200 L of M9 buffer (22 mM KH2PO4, 
28 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4). Finally, C. elegans eggs were inoculated in a NGM I 
plate already prepared with E. coli OP50, which was kept at 20 ºC. 
2.3.2 C. elegans killing assays 
Nematode killing assays were performed essentially as described by Sousa et al. [135]. Liquid cultures 
of the Burkholderia strains used in this work were grown overnight and 50 L of each suspension were 
inoculated on 35 mm diameter plates of nematode growth medium II [NGM II agar plates contained 
0.3% (w/v) NaCl, 0.35% (w/v) Bactopeptone and 1.7% (w/v) Agar. This medium was supplemented 
with 0.05 mM Nystatin, 25 mM KPO4 buffer (796 mM KH2PO4, 204 mM K2HPO4. pH 6.0), 1 mM 
CaCl2, 1 mM MgSO4, 0.02 mM Uracil and 0.01 mM Cholesterol] [136]. NGM II plates were incubated 
at 37 ºC for 24 h, allowing the formation of a bacterial lawn, in which 18 to 30 hypochlorite-
synchronized L4 larvae of C. elegans DH26 (obtained from the Caenorhabditis Genetics Centre, 
University of Minnesota, Minneapolis, USA) were inoculated. For worm counting, a Stemi 2000-C 
stereomicroscope (Zeiss) at 50 of magnification was used. In order to keep C. elegans DH26 strain 
sterile, plates were incubated during 5 days at 25 °C. Morphological appearance and viability of the 
worms were assessed daily. Nematodes were considered dead when failed to respond to touch. The 
results presented are mean values of two independent experiments, each comprising three replicates. 
NGM II plates inoculated with E. coli OP50 were used as a control.  
2.4 Biofilm formation and cell surface hydrophobicity assays 
2.4.1 Biofilm formation ability 
Biofilm formation assays were performed based on the methodology described by Sass et al. [16] and 
O’Toole and Kolter [137]. Overnight liquid cultures of the Burkholderia strains under study were 
performed in 4 mL of Luria-Bertani Broth (LBB; 1% (w/v) Triptone, 1% (w/v) NaCl, 0.5% (w/v) Yeast 
extract) at 37 ºC with orbital agitation. After 16 h of incubation, 25 mL of LBB medium were inoculated 
at an initial OD640 nm of 0.1 and incubated under the same conditions, until mid-log phase was reached. 
These cultures were diluted to a standardized OD640 nm of 0.5 and 20 L were used to inoculate each well 
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of a 96-well polystyrene microtiter plate (Greiner Bio-One) containing 180 L of LBB. Plates were 
incubated at 37 ºC for 24 or 48 h without agitation. Sterile growth medium was used as negative control. 
In order to quantify the biofilm formation, culture medium and the unattached bacterial cells were 
removed by rinsing the wells with 200 l of distilled water, at least three times. Adherent bacteria were 
stained with 200 L of 1% (w/v) crystal violet during 15 min at room temperature. After three gentle 
rinses with 200 L of distilled water, the dye associated to the attached cells was solubilized in 200 L 
of 95% (v/v) ethanol. Biofilm was quantified by measuring the absorbance of the solution at 590 nm in 
the SPECTROstar Nano Microplate Reader (BMG LABTECH). Three independent experiments 
comprising four dependent replicates were performed.  
2.4.2 Bacterial adhesion to hexadecane  
The bacterial adhesion to hydrocarbon (BATH) [138] was used to determine the cell surface 
hydrophobicity of the B. cenocepacia J2315 and B. cenocepacia SJ2 strains. Cultures were grown in LB 
liquid medium for 24 h and harvested by centrifugation (16,000 x g, 5 min, room temperature). Cell 
pellet was washed twice and diluted in 1X PBS buffer pH 7.4 (140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 1.8 mM KH2PO4) to an OD640 nm of 0.6. These cell suspensions were divided in 1.5 mL 
aliquots and then mixed with volumes of hexadecane (Merck) ranging from 0-800 μL. Glass test tubes 
were vortexed for 20 s and the phases (aqueous phase – hexadecane phase) were allowed to separate for 
30 min. After this time, the OD640 nm was measured in the Hitachi U-2000 spectrophotometer. 
Hydrophobicity (%) was calculated using the formula [1-(ODaq/ODi)]100, where ODi represents the 
initial cell suspension OD640 nm and ODaq is the aqueous phase OD640 nm. Results are mean values of two 
independent experiments. 
2.5 Motility assays  
2.5.1 Swimming assays 
Swimming assays were performed as described by Deziel et al. [139]. Tryptone swim agar plates 
containing 1 % (w/v) Triptone, 0.5 % (w/v) NaCl, and 0.3 % (w/v) Agar were spot-inoculated with 2 
µL of exponentially growing Bcc cultures, previously diluted to a standardized OD640 nm of 1. The 
swimming diameters were measured after incubation for 48 h at 37 ºC. Results are the mean values of 
two independent experiments. 
2.5.2 Twitching motility assays 
Twitching assays were performed accordingly to the method described by Deziel et al. [139]. With the 
help of a toothpick, B. cenocepacia colonies from fresh plates were stab-inoculated through a thin LB 
agar layer [1% (w/v) Agar] until reach the polystyrene surface of the plate. The blurred zone of growth 
at the agar-plate interface was measured after 72 h of incubation at 37 ºC. Results are the mean values 
of two independent experiments. 
2.6 Stress susceptibility experiments  
2.6.1 Heat stress susceptibility 
The survival of the B. cenocepacia strains to heat stress was tested by incubating 4 mL of LB medium 
until the cultures reached late-exponential phase. After this time, aliquots of 100 μL were incubated at 
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50 ºC and after 0, 5 and 15 min of incubation, aliquots were serially diluted and inoculated on LB plates, 
incubated at 37 ºC for 24 h and the number of CFUs/mL was counted.   
The relative number of bacterial survivors was calculated by dividing the number of CFUs/mL after the 
heat stress by the initial number of CFUs/mL. Results are mean values of two independent experiments. 
2.6.2 Anionic detergent shock experiments 
In order to evaluate the susceptibility of B. cenocepacia J2315 and SJ2 strains to SDS, 25 mL of LB 
medium were inoculated and incubated (OD640 nm 0.1) until mid-log phase. The cells were then collected, 
washed and diluted to an OD640 nm of 0.7 with 20 mM Tris (pH 8). To evaluate the mortality kinetics of 
each strain, pulses of SDS to a final concentration of 0.1%, 0.5%, 1% and 5% (v/v) were added and the 
bacterial mixture OD640 nm was measured at room temperature during 10 min, using a double-beam 
spectrophotometer (Hitachi U-2000). Positive controls, without SDS, were also performed.  
The cell lysis rate was calculated based on the decay rate of each curve. Results are mean values of two 
independent experiments. 
2.7 Antibiotic susceptibility testing  
B. cenocepacia strains J2315 and SJ2 susceptibility to the antibiotics imipenem, amikacin, tetracycline, 
streptomycin, ciprofloxacin, aztreonam, ceftazidime, gentamicin and trimethoprim, as well as B. 
cenocepacia J2315 (pMLS7) and B. cenocepacia J2315 (pMya2) susceptibility to tetracycline and 
streptomycin were assessed by determining the minimal inhibitory concentration (MIC) by broth micro 
dilution technique [140]. Stock solutions of each antibiotic were prepared in Mueller Hinton (MH) liquid 
medium (Fluka) at a final concentration of 1,024 μg/mL. A 96-well polystyrene microtiter plate (Greiner 
Bio-One) was prepared containing 75 L of MH liquid medium in each well. Serial 1:2 dilutions of each 
antibiotic were made in order to obtain final test concentrations ranging from 1,024 μg/mL to 0.125 
μg/mL. The wells were inoculated with 75 L of each tested organism with approximately 1106 
CFU/mL (OD640 nm of 0.0025). The plates were incubated at 37 ºC for 24 h. After this time, the wells 
were examined for turbidity (growth) and their OD640 nm was measured in a SPECTROstar Nano 
Microplate Reader (BMG LABTECH). The lowest concentration of antimicrobial agent capable of 
preventing growth of the tested organism was considered the MIC value. Wells without antibiotic or 
without organism inoculum were considered positive and negative controls, respectively. These 
experiments were performed four times. 
2.8 Statistical analysis 
The results here presented for biofilm formation assays were tested for statistical significance with SPSS 
statistical package (version 21, SPSS Inc., Chicago, IL, USA). Results are presented as mean values and 
standard deviations (SD). The Kolmogorov-Smirnov test was used to assess the normality of continuous 
variables. For the variables with a normal distribution the homogeneity of variances was evaluated using 
the Levene test. The Student’s paired t-test was used to evaluate the differences in mean values of the 
results observed in cultures with different treatments. For non-normal variables, the nonparametric 
Mann-Whitney U test was used. A p-value < 0.05 was considered statistically significant. The figures 
presented in this work correspond to representative results of the assays performed.  
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2.9 Bioinformatics analysis  
2.9.1 MavA sRNA bioinformatics analysis 
In order to confirm MavA sRNA conservation among bacterial genus, BLAST searches were performed 
against publicly available genomes using the BLASTN algorithm present at NCBI, as mentioned in 
section 2.2.4. Conserved domains were searched using NCBI’s conserved domain database [141]. The 
region of the putative sequence encoding MavA sRNA was extensively analysed for the presence of 
putative promoters using the Virtual Footprint and PRODORIC promoter analysis server [142] and the 
promoter recognition program BPROM [143], followed by a prediction of Rho-independent 
transcription terminators with the FindTerm [143] and ARNold [22] web tools. The search for functional 
homologues of MavA was performed using the sRNAMap database [144]. The putative consensus 
secondary structure of MavA was retrieved with the RNAalifold web tool [145], whereas a previously 
multiple alignment of RNA sequences belonging to Bcc bacteria was performed with the LocARNA 
[146] tool, both tools available at the Freiburg RNA Tools web server [147]. Putative mRNA targets of 
MavA sRNA were searched using TargetRNA2 (version 2.01) [148] and RNApredator (version 1.55) 
[149] web tools. A minimum seed of 7 nt and a hybridization target region window size of -80 to +20 
around the translation start site were used. 
2.9.2 Hypothetic ORF bioinformatics analysis  
The nucleotide and amino acid sequence obtained to the hypothetical protein (section 2.2.4) were used 
for a BLAST search against the genome and annotated ORFs from several bacterial species, using the 
BLASTN and BLASTP algorithms, respectively, present at NCBI, in order to analyse its conservation. 
The presence of putative conserved domains was performed in NCBI’s conserved domain database 
[141], while the presence of putative promoters was analysed using the Virtual Footprint and 
PRODORIC promoter analysis server [142] and the promoter recognition program BPROM [143]. 
Clustal Omega tool was used to perform multiple alignments for the protein sequences retrieved from 
BLASTP (https://www.ebi.ac.uk/Tools/msa/clustalo/) [150] and the consensus secondary structure was 
predicted by the JNet algorithm from JPred4 web server [151]. The various physicochemical properties 
of the hypothetical protein were computed with ProtParam tool [152], available at ExPASY 
bioinformatics resource portal (http://web.expasy.org/protparam/). With the ultimate goal to identify a 
potential sub-cellular localization for the hypothetic protein, SignalP 4.1 [153] and TatP 1.0 [154] web 
servers were used to predict the presence and location of signal peptide cleavage sites, whereas 
SecretomeP 2.0 [155] and LocTree3 [156] web servers were used to predict the presence of a classical 
or non-classical protein secretion pathway. Moreover, TMHMM Server v. 2.0 was used to predict the 





3. RESULTS AND DISCUSSION 
3.1 Characterization of the B. cenocepacia J2315 chromosome 1 intergenic region flanked by 
genes gyrA and ompA  
The B. cenocepacia J2315 derived mutant SJ2 was previously obtained by the iBB research team by 
random plasposon mutagenesis with pTnMod-OCm [135]. This mutant was identified after the 
qualitative screening for mutants exhibiting reduced virulence towards the nematode C. elegans. The 
region interrupted by the plasposon insertion is located in B. cenocepacia J2315 chromosome 1, between 
the gyrA and ompA putative encoding genes. This 555 bp intergenic region (IGR) was examined in this 
study. 
The plasposon was found to be inserted at 133 nt from the start codon of the ORF putatively encoding 
an outer membrane protein A (OmpA), and 413 nt from the start codon near the ORF putatively encoding 
a GyrA enzyme. Recently, the coding sequence of the B. cenocepacia J2315 OmpA-like protein was 
shown to display an extensive 5’ UTR region, comprising approximately 151 nt [16]. 
In order to gain further insights on the possible function of this IGR, we have initiated this work by 
analysing the possible effects of the plasposon insertion on ompA gene integrity and functionality, since 
the transcript from the putative OmpA family protein could be affected in its 5’ UTR. Total RNA was 
extracted from exponentially growing B. cenocepacia J2315 and B. cenocepacia SJ2 cells, cultured in 
rich medium and the corresponding cDNA was synthesized. The nucleotide sequence of the ompA gene 
was retrieved from the Burkholderia Genome Database and specific primers were designed for the 
amplification by PCR of the 669 bp fragment putatively encoding this protein. The results obtained (Fig. 
3.1 A) demonstrated that the transcription of the gene encoding the OmpA-like protein is not affected 
by the plasposon insertion, since in both cDNA samples the band obtained presented the predicted size.  
A Western blot assay was performed to evaluate if the ompA mRNA of the mutant strain was functional. 
The detection of a band with a molecular mass inferior to 25 kDa is consistent with the molecular mass 
of OmpA-like protein (23.97 kDa), confirming the ompA mRNA translation in the mutant SJ2 (Fig. 3.1 
B). In E. coli ompA mRNA stability is acquired due to the presence of two stem-loops in the 5’ UTR. 
The Hfq protein binds to the single-stranded regions adjacent to the stem-loops, modifying the mRNA 
stability (reviewed in [158]). Since the plasposon is inserted 8 nt after the predicted 5’ UTR beginning 
of the B. cenocepacia J2315 OmpA-like protein and assuming the mRNA presents the same structure 
as described for E. coli ompA mRNA, then the plasposon could not interfere with the single-stranded 
regions and affect ompA mRNA functionality.  
Figure 3.1 Detection by RT-PCR of the transcript from the 
ORF putatively encoding an OmpA-like protein, located in 
B. cenocepacia J2315 chromosome 1 (A) and assessment of 
the ompA mRNA functionality by Western blot (B). The 
cDNA was generated from total RNA collected from 
exponentially grown cells. Lanes: L1- GeneRulerTM Low Range 
DNA Ladder; 1 – cDNA from B. cenocepacia J2315; 2 – cDNA 
from B. cenocepacia SJ2; C – negative control (without 
template); 3 and 4 - negative controls, using as template the 
initial total RNA samples of B. cenocepacia J2315 and B. 
cenocepacia SJ2, respectively; L2 – Molecular mass ladder 
(Unstained Protein Molecular Weight Marker, Fermentas); 5 – 
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Since the OmpA-like protein was not affected by the plasposon insertion, the previously observed 
change in the virulence of the SJ2 mutant towards C. elegans was hypothesized to be due to a transcript 
interrupted in the IGR between ompA and gyrA genes. As a first approach, an ORF search was performed 
for the IGR nucleotide sequence. Five non-annotated ORFs were predicted. However, due to their 
predicted locations, the hypothetical OFRs were not interrupted by the plasposon (data not shown). 
Therefore, a new ORF search was performed adding 38 nt of the sequence encoding the OmpA-like 
protein to the query sequence, since an initiation codon was located in the 5’ region of the ompA 
encoding gene. Six non-annotated ORFs (ORF1 to ORF6) were predicted (Fig. 3.2). The putative ORF3 
was found to be the ORF more likely affected by the plasposon, since its insertion could result in the 
interruption of the putative ORF3 sequence. 
 
 
Figure 3.2 ORF prediction. Information 
of each predicted ORF in the nucleotide 
sequence from the IGR plus 38 nt from 
the nucleotide sequence encoding the 
OmpA-like protein, retrieved from the 
ORF Finder tool. The ORF3 was further 
considered. 
Northern blot assays were performed by the iBB research team to identify the transcription products 
originating from the IGR, using DNA probes against different regions of both DNA strands. Preliminary 
results with Int3_UP primer (section 2.2.7) showed the presence of a transcript in the reverse strand, 
with approximately 100 bp (data not shown).  
To further characterize the transcript obtained by the Northern blot assay, 5’ and 3’ RACE analysis were 
carried out in the present work against the reverse strand and using pure total RNA samples to determine 
the 5’ and 3’ ends of this transcript. The 5’ RACE analysis of the intergenic region was performed using 
as 5’ RACE gene specific outer primer Int3_UP (section 2.2.7) and a band of approximately 100 bp, 
without the 45 bp belonging to the 5’ RACE adapter, was obtained (Fig. 3.3 lane 2). Then, an analysis 
using as 5’ RACE gene specific inner primer RACE 1 (section 2.2.6) was performed and a band of 
approximately 40 bp was obtained, without the 45 bp of the 5’ RACE adapter (Fig. 3.3 lane 1). These 
results demonstrated the presence of a transcript with a shorter 5’ end than the expected for the putative 
ORF3. In this case, the bands obtained should comprise a size higher than 335 and 294 bp, respectively. 
Since the transcript obtained by 5’ RACE appears to start only 100 nt upstream the putative ORF3 stop 
codon and 188 nt downstream its start codon, a specific primer to assess its 3’ end was designed for the 
initial sequence of the transcript. 3’ RACE analysis were performed using the 3’ RACE gene specific 
outer primer RACE 2 (section 2.2.7). Two bands were obtained with approximately 30 bp and 200 bp 
(Fig. 3.3 lane 3), without the 45 bp belonging to the 3’ RACE adapter. These fragments were blunt-end 
cloned into the HincII site of pUC19 plasmid and the resulting plasmids were used to transform E. coli 
α-DH5 competent cells. 
At the moment, it was not possible to sequence the 5’ RACE fragments. Nevertheless, the 200 bp 
fragment obtained by 3’ RACE allowed the identification of a transcript with a size of 167 nt in the 
reverse strand of B. cenocepacia J2315 chromosome 1, spanning from nucleotides 3,238,624 to 
3,238,791. It should be noted that this transcript could belong to the hypothetical ORF3 since it is present 






Figure 3.3 Analysis of 5’ and 3’ Rapid Amplification of cDNA Ends (RACE) in 2% (w/v) 
agarose gel electrophoresis. Lanes: L- GeneRulerTM Low Range DNA Ladder; 1 – 5’ end mapping 
using primers 5’ RACE Inner and RACE 1; 2 - 5’ end mapping using primers 5’ RACE Inner and 
Int3_UP; 3 - 3’ end mapping using primers 3’ RACE Outer and RACE 2. cDNA was generated 
from total RNA samples of exponentially grown B. cenocepacia J2315 cells. 
In this case, if the transcript comprised only the 167 nt obtained with the 3’ RACE, the plasposon 
insertion would be situated at a distance of 20 nt upstream of the first nucleotide of the transcript. 
However, it is possible that the transcript has a larger size, since the amplification with 5’ RACE gene 
specific primers Int3_UP and RACE 1 primers points out to the presence of, at least, 12 additional nt at 
its 5’ end. Therefore, the transcript likely comprises 179 nt and the plasposon is potentially situated only 
8 nt upstream of its encoding sequence. 
Specific primers were designed for the amplification of the putative sequence encoding the transcript 
and RT-PCR experiments were carried out using the same cDNA samples employed in the RT-PCR of 
OmpA-like protein. The transcript under study was confirmed to be present under the conditions used 
in B. cenocepacia J2315 strain (Fig. 3.4, lane 1). However, its expression was also confirmed for SJ2 
mutant (Fig. 3.4, lane 2) suggesting that it is not interrupted by the plasposon.  
 
 
Figure 3.4 Detection by RT-PCR of the transcript obtained by 5’ 
and 3’ RACE from B. cenocepacia J2315 chromosome 1. The 
cDNA was generated from total RNA collected from exponentially 
grown cells. Lanes: L1- GeneRulerTM 1 kb Plus DNA Ladder; 1 – 
cDNA from B. cenocepacia J2315; 2 – cDNA from B. cenocepacia 
SJ2; C – negative control (without template); 3 and 4- negative 
controls, using as template the initial total RNA samples of B. 
cenocepacia J2315 and B. cenocepacia SJ2, respectively; 5 – positive 
control, with genomic DNA from B. cenocepacia J2315. 
The abovementioned genetic elements appear to have no involvement in the virulence attenuation of the 
B. cenocepacia SJ2 mutant strain towards C. elegans.  
Since the transcript obtained by 5’ RACE analysis started approximately 176 nt downstream the 
predicted ORF3 start codon and 100 nt upstream its stop codon and it is not interrupted in SJ2 mutant 
strain, we hypothesized that this transcript could belong to another element present in the IGR. 
Therefore, a specific forward primer was designed for the nucleotide sequence retrieved as belonging to 
the hypothetical ORF and RT-PCR experiments were carried out with the cDNA templates used in the 
abovementioned experiments. The transcription of the putative ORF3 was confirmed in B. cenocepacia 
J2315 (Fig. 3.5 lane 1). Furthermore, it was also observed that the plasposon is interrupting the ORF3, 
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Figure 3.5 Detection of the transcript from the non-annotated ORF3 from B. cenocepacia J2315 by RT-PCR. Lanes: 1 
– cDNA from B. cenocepacia J2315; 2 – cDNA from B. cenocepacia SJ2; L- GeneRulerTM 1 kb Plus DNA Ladder; 3 and 4- 
negative controls, using as template the initial total RNA samples of B. cenocepacia J2315 and B. cenocepacia SJ2, 
respectively; C – negative control (without template); 5 – positive control, with genomic DNA from B. cenocepacia J2315. 
These results indicate the presence of at least two distinct genetic elements in the IGR, namely a 
transcript and a putative ORF. Since the sequence encoding the transcript obtained by RACE analysis 
does not contain start or stop codons nearby and due to its small size, we hypothesized that this sequence 
constitutes a sRNA. 
Although the data collected from the ORF Finder tool did not allow an accurate chromosome mapping 
of the non-annotated ORF3, it allowed the prediction of its presence in the reverse strand of B. 
cenocepacia J2315 chromosome 1, spanning from nucleotides 3,238,700 to 3,238,982 (Fig. 3.6). It 
should be mentioned that the sequence corresponding to ORF3 overlaps the nucleotide sequence 
encoding the sRNA at least 100 nt and the putative sequence encoding the OmpA-like protein in 29 nt 
(Fig. 3.6). In B. cenocepacia SJ2, the plasposon is inserted 160 nt downstream the ATG codon of the 
putative ORF3 and 108 nt upstream its predicted stop codon (TAA). After the genome analysis of B. 
cenocepacia J2315, the 5’ RACE analysis above described was found to have been performed using 
primers for the overlapping sequence. For this reason, the 5’ RACE analysis is expected to reveal two 
different bands corresponding to ORF3 and sRNA.  
These elements will be characterized in the further sections. 
Figure 3.6 Genetic organization of the IGR locus 
interrupted by the plasposon. A putative sRNA and a 
non-annotated ORF were confirmed to be present in the 
reverse strand of B. cenocepacia J2315 chromosome 1 
IGR. Furthermore, the hypothetical ORF3 was found to 
be the element interrupted by the plasposon insertion. 
The hypothetical ORF3 is present in the reverse strand of 
the chromosome 1, overlapping the putative ompA gene 
and the sRNA. The numbers indicate the nucleotide 
positions, whereas the inverted triangle and bold line 
represent the localization of the plasposon. 
3.2 Biocomputational analysis and phenotypic characterization of the hypothetical protein 
encoded by ORF3 
3.2.1 The hypothetical protein ORF3 is conserved among Burkholderia and has high homology 
with annotated ORFs 
The B. cenocepacia J2315 derived mutant SJ2 was previously identified by the iBB research team 
through the qualitative screening of mutants with reduced virulence towards C. elegans (unpublished 
results). The results from this work revealed that the plasposon insertion interrupted a non-annotated 






























the 3,239,456 nt region of the reverse strand of B. cenocepacia J2315 chromosome 1, i.e., 150 nt from 
the start codon of ORF3, was recently identified by Sass et al. [16]. To investigate the expression of the 
putative protein, the 5’ hypothetical regulatory region upstream the nucleotide sequence predicted to 
encode ORF3 was analysed with the bacterial promoter prediction tools BPROM (Softberry) [143] and 
Virtual Footprint (Prodoric) [142]. Although no results were obtained with the BPROM tool, the Virtual 
Footprint tool predicted, with a high score (9.76 out of 10), the existence of a region where the P. 
aeruginosa transcriptional regulator RhlR could bind, 190 nt upstream the putative start codon of ORF3 
encoding sequence. RhIR transcription regulator plays a central role in QS response [159].  
Analysis carried out with the ProtParam tool [152] showed that the hypothetical protein has a predicted 
molecular mass of approximately 10.53 kDa and a pI of 10.20. In addition, the protein was predicted to 
be unstable [instability index (II) of 41.75] and hydrophilic (grand average of hydropathicity index, 
GRAVY, - 0.141) [160].  
The ORF3 nucleotide sequence was found to be conserved among 16 Bcc members and other 
Burkholderia species with minimal identity values of 94%. Moreover, the deduced amino acid sequence 
of ORF3 was found to be 98% identical to that of a recently annotated ORF belonging to the Bcc strain 
B. multivorans ATCC 17616 and 96% identical to the amino acid sequences of 5 annotated ORFs from 
B. pseudomallei strains (Fig. 3.7). No functions were described so far for these hypothetical proteins. 
Homologues with a sequence identity of 69% and 29% were found with annotated ORFs of unknown 
function from a Paraburkholderia rhizoxinica strain and from a Bacteroidetes bacterium, respectively. 
However, no conserved motifs could be predicted.  The in silico consensus secondary structure of ORF3 
was predicted with JPred4 web server [151] after the alignment of Burkholderia amino acid sequences 
(Fig. 3.7). Two α-helices and four β-sheets were predicted for the protein secondary structure. Moreover, 
extended regions of the amino acid sequence seem to be conserved among all the identical proteins from 






Figure 3.7 Prediction of the consensus secondary 
structure of B. cenocepacia J2315 ORF3 protein, by 
JPred4 web server. Multiple alignment of the amino acid 
sequences of ORF3 homologs from B. multivorans ATCC 
17616 (BAG42920), B. pseudomallei MSHR7500 
(KGS77515), B. pseudomallei (KGD22390), B. 
pseudomallei TSV28 (KGX68826), B. pseudomallei 
(KGC39050) and B. pseudomallei (KGD58220). Highly 
conserved regions are coloured in dark blue, while semi-
conserved regions are coloured in light-blue. Asterisks 
indicate that the amino acid residue is present in all the 
sequences. One dot or two dots indicate the presence of 
conserved or semi-conserved residue substitutions. The 
symbols above the aligned sequences represent the 
secondary structure elements, green spirals represent α-
helices and yellow arrows represent β-sheets.  
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The predicted cellular localization of the B. cenocepacia J2315 ORF3 was analysed using different web 
tools. While SignalP 4.1 [153] and TaP 1.0 [154] servers failed to predict the presence of a N-terminal 
signal peptide and, consequently its localization, LocTree3 [156] webserver predicted with 94% 
accuracy the occurrence of secretion, suggesting that this protein is extracellular. The ClyA cytotoxin is 
an example of a bacterial protein secreted via the non-classical secretion pathway, being released from 
E. coli cells in vesicles detached from the outer membrane [161]. Indeed, SecretomeP 2.0 Server [155] 
predicted the secretion of the hypothetical protein by the non-classic pathway. Based on these 
bioinformatic results, it is possible that ORF3 protein is an extracellular protein. 
3.2.2 B. cenocepacia J2315 ORF3 does not impair growth ability 
The growth ability of the wild-type (WT) strain and SJ2 mutant was compared in rich medium (LB) and 
minimal medium (M9) at 37 ºC, with orbital agitation (Fig. 3.8). The strains showed similar specific 
growth rates when growing in LB medium, since the calculated specific growth rate was approximately 
0.38 h-1 ± 0.01 for the WT strain and 0.37 h-1 ± 0.01 for the SJ2 mutant (Fig 3.8 A). Although it was 
not possible to determine the specific growth rate in M9 medium due to the lack of time points during 
the exponential and stationary growth phases, a reduction in the OD640 nm after 72 h of incubation was 
registered for the SJ2 (Fig. 3.8 B). This result suggests that the ORF3 is relevant for the bacterial growth 









Figure 3.8 Growth curves of B. cenocepacia strains J2315 (■) and SJ2 () in LB medium (n=2) (A) and M9 medium (n=3) 
(B) at 37 ºC. Values are presented as mean  SD. 
We also analysed the soluble proteins profile of B. cenocepacia J2315 and B. cenocepacia J2315 derived 
mutant SJ2. For this purpose, B. cenocepacia J2315 and B. cenocepacia SJ2 strains were incubated for 
8 h in rich medium (LB) and for 24 or 48 h in minimal medium (M9). Samples of crude extracts prepared 
from cells harvested at each time point were analysed by Tricine-SDS-PAGE to study the effect of the 
interrupted ORF on the protein pattern of the total soluble proteins. As shown in Fig. 3.9, no significant 
differences on protein patterns could be detected. 
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Figure 3.9 Tricine-SDS-PAGE analysis of the total soluble proteins obtained from B. cenocepacia J2315 or B. 
cenocepacia SJ2 strains. Total soluble proteins were obtained from cells of B. cenocepacia J2315 and B. cenocepacia SJ2 
after incubation at 37 ºC for 8 h in LB rich medium (A) and 24 or 48 h in M9 minimal medium (B) and diluted to a final OD640 
nm of 0.4. Lanes: L – Molecular mass ladder (Unstained Protein Molecular Weight Marker, Fermentas); 1- total soluble proteins 
from B. cenocepacia J2315; 2 - total soluble proteins from B. cenocepacia SJ2; 3 and 5- total soluble proteins from B. 
cenocepacia J2315 after an incubation period of 24 or 48 h in M9, respectively; 4 and 6- total soluble proteins from B. 
cenocepacia SJ2 after an incubation period of 24 or 48 h in M9, respectively. 
3.2.3 B. cenocepacia SJ2 mutant strain forms thicker biofilms and has an increased cell surface 
hydrophobicity  
To evaluate the role of ORF3 on biofilm formation the B. cenocepacia J2315 and SJ2 strains were 
cultivated in microtiter plates and the amount of biofilms formed was assessed after 24 and 48 h in LBB 
medium [1% (w/v) NaCl], at 37 ºC. The results presented in Fig. 3.10 show that the mutant strain forms 





Figure 3.10 Assessment of biofilm formation by B. cenocepacia J2315 
(black bars) or B. cenocepacia SJ2 (grey bars) strains in polystyrene 
microtiter plates. Biofilm formation was quantified after 24 and 48 h of 
incubation at 37 ºC in LBB medium without agitation. Results are 
expressed as mean ± SD. Significant differences were determined using 
the unpaired t- test (n=3). ***p < 0.001 and *p < 0.05 when compared with 
the biofilm formation by B. cenocepacia J2315 cells. 
 
The hydrophobic properties of microbial cells are correlated with cell surface composition and has been 
ascribed an important role in the adherence of microorganisms to substrata, contributing to biofilms 
formation (reviewed in [162]). A hypothesis for the ability of SJ2 strain to form thicker biofilms is the 
increased hydrophobicity of its cells surface. Therefore, experiments of bacterial adhesion to the solvent 
hexadecane (BATH) [138] were performed (Fig. 3.11). The mutant SJ2 cells exhibited an increased cell 
surface hydrophobicity when compared to the WT strain. An alteration in the outer membrane of the 
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Figure 3.11 Assessment of B. cenocepacia J2315 (■) and B. 
cenocepacia SJ2 () cells hydrophobicity. Bacterial adhesion to 
hexadecane was evaluated by the addition of 0-800 µL of 
hexadecane to 1.5 mL bacterial suspensions with an OD640 nm of 0.6, 
followed by OD640 nm measurement of the aqueous phase. Values 
represent mean  SD and are expressed as percentages relative to 
the OD640 nm of the initial cell suspension. Statistical analysis 
performed with the unpaired t- test (n=2). 
3.2.4 The twitching motility of B. cenocepacia SJ2 strain is apparently affected  
Since SJ2 mutant strain forms thicker biofilms than the WT strain, experiments regarding flagellar-
mediated (swimming) [163] and type IV pili-mediated (twitching) motility [164] were performed. While 
no alterations were observed for the swimming motility, the twitching motility was decreased in the 
mutant (Fig 3.12). These results correlate with those obtained in section 3.2.3, indicating that the SJ2 
strain outer membrane topology could be affected. 
 
Figure 3.12 Comparison of B. cenocepacia J2315 and B. cenocepacia SJ2 swimming (A) and twitching (B) motility. Bars 
indicate the colony diameters obtained for B. cenocepacia J2315 (black) or B. cenocepacia SJ2 (grey), after 48 h of incubation 
in adequate solid media at 37 ºC (A) or 72 h at 37 ºC (B). Results are expressed as mean ± SD. Statistical analysis performed 
with the unpaired t- test (n=2). 
3.2.5 B. cenocepacia SJ2 strain shows increased mortality at 50 ºC and cell lysis rate in the 
presence of SDS  
To further investigate the role of the hypothetical protein in the bacterial membrane stability, stress 
susceptibility experiments involving exposure to heat or SDS stress were performed. 
Membrane fatty acid composition and fluidity are two components that have been shown to affect 
bacterial thermal resistance [165,166]. Thus, B. cenocepacia J2315 and SJ2 strains resistance to heat-
shock stress was evaluated. Although only two replicates have been performed and consequently, a 
statistical analysis could not be done, an accentuated decrease in SJ2 survival was observed when 
compared with the WT strain (Fig. 3.13). After 5 min of exposure to 50 ºC, the percentage of B. 
cenocepacia J2315 survivors was approximately 5-fold higher than the percentage of B. cenocepacia 
SJ2 survivors. Increasing the exposure time to the thermal stress to 15 min led to a general decay in the 
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percentage of bacterial survivors. However, the percentage of survivors for the WT strain was 
approximately 2%, while SJ2 survivors were almost non-detectable (0.2%). 
Annous et al. [165] and Sampathkumar et al.  [166] have shown for Pediococcus spp. and Salmonella 
enteritidis, respectively, that the presence of unsaturated fatty acids in the membranes leads to higher 
membrane fluidity and, consequently, reduced thermal resistance to high temperatures. Our results 
suggest that the hypothetical protein could be related to the maintenance of the membrane fluidity, since 
an interruption in the respective ORF drastically decreased the percentage of survivors upon exposure 





Figure 3.13 B. cenocepacia SJ2 mutant strain is more susceptible to 
heat-shock stress than the WT strain. Cells from exponentially 
growing cultures were harvested and exposed for 5 and 15 min to 50 
ºC. Aliquots with 100 µL were then spread onto the surface of LB 
plates. After 24 h at 37 ºC, the number of CFUs/ mL was counted and 
the relative number of bacterial survivors was calculated. Black bars 
represent B. cenocepacia J2315 strain; grey bars represent B. 
cenocepacia SJ2 strain. Values represent mean  SD and are expressed 
as percentages relative to non-exposed control cells (n=2).  
 
Denaturing detergents, such as the anionic detergent SDS, can cause membrane disruption by interfering 
with the inter- and intra-molecular protein-protein interactions [167]. 
Since B. cenocepacia SJ2 strain possibly presents structural changes at the membrane level, the mortality 
kinetics of B. cenocepacia J2315 and SJ2 strains to pulses of different SDS concentrations were 
performed by measuring the OD640 nm at room temperature during 10 min. The cell lysis rate of SJ2 
mutant strain was higher than that of the WT for all the concentrations of SDS tested (Fig. 3.14). For a 
final concentration of 0.1% (v/v), the cell lysis rate of SJ2 strain presented approximately a 3-fold 
increase when compared to the WT cell lysis rate. For the final SDS concentrations of 0.5% and 1% 
(v/v) it was observed an increase of 2.5-fold and 1.5-fold increase for 5% (v/v) of SDS.  
Indeed, a higher cell lysis rate was expected for the mutant strain since the outer membrane is likely 
altered and consequently, protein-protein interactions can be weakened. This would cause an effortless 
disruption of the intramembrane interactions by SDS. 
 
 
Figure 3.14 B. cenocepacia SJ2 mutant strain () exhibits an increased 
cell lysis rate upon exposure to SDS, when compared to B. cenocepacia 
J2315 (■). Pulses of SDS to a final concentration of 0. 1%, 0.5%, 1% and 
5% (v/v) were added to the bacterial suspension with an initial OD640 nm of 
0.7 and the OD640 nm was measured at room temperature during 10 min. 
Results are expressed as mean  SD and as percentages relative to non-
treated control cells. Statistical analysis performed with the unpaired t- test 
(n=2). 

























3.2.6 The B. cenocepacia SJ2 strain is more susceptible to ceftazidime, imipenem and 
tetracycline 
The effects of the interrupted ORF on antibiotics susceptibility were evaluated by the broth micro 
dilution technique [140]. A total of nine antibiotics from different classes and currently used in the 
clinical setting were used in this study. These antibiotics included -lactams, more specifically the 
cephalosporin ceftazidime, a carbapenem (imipenem) and a monobactam (aztreonam); 
aminoglycosides, such as amikacin, streptomycin and gentamicin; tetracycline; fluoroquinolones, in 
particular ciprofloxacin, and the antimetabolite trimethoprim. The MIC values obtained are presented 
in table 3.1, showing an increased susceptibility of the SJ2 mutant to two -lactams (imipenem and 
ceftazidime) with a 2 and 4-fold decrease in the MIC value, respectively, and to the antibiotic 
tetracycline by presenting a 2-fold decrease in the MIC value. 
Table 3.1 Antibiotic susceptibility of B. cenocepacia J2315 and B. cenocepacia J2315 derived mutant SJ2. MIC values 
were assessed by the microdilution method (n=4) and are presented in µg/mL. Abbreviations: IPM - Imipenem; AMK - 
Amikacin; TET - Tetracycline; CIP - Ciprofloxacin; ATM - Aztreonam; SM - Streptomycin; CAZ - Ceftazidime; GEN - 
Gentamicin; TMP – Trimethoprim. 
 
-lactams are small hydrophilic drugs that use pore-forming porins to enter the cells [168] and act by 
interfering with penicillin-binding proteins involved in the synthesis of the bacterial peptidoglycan layer, 
leading to an inhibition of the cell wall synthesis (reviewed in [169]). Tetracyclines are hydrophobic 
drugs that can enter the cells by lipid-mediated or porin-mediated pathways [170] and act by blocking 
protein synthesis [171]. These two classes of antibiotics are very distinct in their mode of action, 
however they can gain access to the cell interior through similar porins [170].  
Interestingly, a few charged residues of the OmpF porin constriction zone have been demonstrated to 
affect -lactams flux and sensitivity, when mutated [172]. However, the bioinformatic tool TMHMM 
Server v. 2.0 [157] does not predict the occurrence of any transmembrane domain in ORF3 protein. 
Further work must be performed to elucidate the role of ORF3 in antibiotic resistance. 
3.2.7 B. cenocepacia SJ2 mutant strain exhibits decreased ability to kill the nematode C. elegans 
To investigate the role of ORF3 protein in B. cenocepacia J2315 virulence, slow-killing experiments 
using the infection model C. elegans were performed as mentioned in section 2.3.  
The B. cenocepacia SJ2 mutant showed a time-dependent decrease on its ability to kill the nematodes 
(Fig. 3.15). While B. cenocepacia J2315 strain was able to reduce to 50% the initial nematode population 
within approximately 1.5 days, the B. cenocepacia SJ2 strain achieved the same level of nematode 
population after, approximately, 2.5 days. The difference between the WT and SJ2 strain in terms of 
nematodes killing efficiency was clearer during days 3 and 4. The WT strain reduced the initial 
population to 18% and 10% by days 3 and 4, respectively, whereas SJ2 mutant caused a more attenuated 
reduction to, approximately, 43% and 30%, respectively, during the same period. Moreover, in the last 
day of this experiment almost no surviving worms could be detected for the WT (approximately 2%), 
while for the SJ2 mutant 15% of the initial worms were still alive. 
Strains IPM AMK TET SM CIP ATM CAZ GEN TMP 
B. cenocepacia J2315 128 256 64 >1,024 8 >1,024 128 1,024 1,024 
B. cenocepacia SJ2 64 256 32 >1,024 8 >1,024 32 1,024 1,024 
33 
The reduced ability of SJ2 to kill the nematodes population cannot be attributed to growth defects, since 
growth curve assays performed in rich medium and under starvation conditions (LB and M9, 
respectively) showed no significant differences (Fig. 3.8). Although no statistical significance was 
obtained, the data herein presented suggests that the ORF3 plays a role in the virulence of B. cenocepacia 
J2315 and might be particularly important in the progression of the infection. It should be noted that to 
confirm these data more experiments should be performed and the SJ2 mutant ability to colonize the 





Figure 3.15 Comparison of E. coli OP50 (purple bars), B. 
cenocepacia J2315 (black bars) and B. cenocepacia SJ2 (grey) 
ability to kill the nematode C. elegans. Values represent mean  
SD and are expressed as percentages relative to the initial number 
of hypochlorite-synchronized L4 larvae of C. elegans DH26 
inoculated (between 18-30). Statistical analysis performed with 
the unpaired t- test (n=2). 
 
 
3.3 Biocomputational analysis and phenotypic characterization of MavA sRNA  
3.3.1 MavA sRNA is specific of the Burkholderia genus and has one functional homologue 
The sRNA identified through the characterization of the B. cenocepacia J2315 derived mutant SJ2 was 
named MavA and comprises an estimated size of 179 nt. To investigate the expression of MavA, the 5’ 
putative regulatory region upstream the nucleotide sequence obtained by 3’ RACE was analysed with 
the bacterial promoter prediction tools BPROM (Softberry) [143] and Virtual Footprint (Prodoric) [142]. 
Both programs retrieved a typical bacterial sigma 70 (σ70) promoter harbouring the canonical -10/-35 
elements [16,173] (Fig. 3.16 A). However, the functionality of this promoter is still not proven. A 
putative TSS in the region 3,238,600 nt of the reverse strand in B. cenocepacia J2315 chromosome 1 
was recently reported [16]. Thus, the predicted TSS is located at a distance of 7 nt relatively to the 
consensus -10 box, according with previous reports [174]. The presence of this promoter and TSS 
support the hypothesis that MavA is larger than 167 bp. In this case, the size obtained by RACE analysis 
would be 236 nt and, opposite to our results, MavA transcription should be affected by the plasposon.  
The 3’ putative regulatory region downstream the mavA nucleotide sequence and upstream the sequence 
encoding GyrA enzyme was analysed using the Rho-independent transcription terminators web tools, 
FindTerm [143] and ARNold [22]. Although only one putative terminator was obtained from each tool, 
both programs retrieved the same sequence, approximately at 55 nt downstream the mavA encoding 
sequence (Fig. 3.16 B). 
 
 




































Regarding the currently available genomes, B. cenocepacia J2315 mavA nucleotide sequence was found 
to be conserved among 17 Bcc members and other Burkholderia species with minimal identity values 
of 88% and 80%, respectively. However, no conserved domains could be detected and it was not 
possible to retrieve mavA homologues within non-Burkholderia genomes, suggesting that MavA sRNA 
is specific to members of the Burkholderia genus. 
 
Figure 3.16 Prediction of putative promoters and Rho-independent transcription terminators of MavA. Relevant 
nucleotide sequence of the 5’ putative regulatory region upstream MavA encoding sequence. The predicted -10 and -35 
elements of the promoter are underlined. The predicted TSS [16] is represented in blue by an arrow at the position +1 (A). 
Relevant nucleotide sequence of the 3’ putative regulatory region upstream MavA encoding sequence. The predicted region of 
the Rho-independent transcription terminator is represented in bold, while the palindromic sequence and the stretch of T’s, that 
demonstrate the possible presence of a GC-rich hairpin [22] are highlighted in purple with arrows and with a box, respectively 
(B). 
The in silico secondary structure of MavA was predicted with LocARNA [146] and RNAalifold [145] 
web tools after the alignment of MavA Bcc sequences (Fig. 3.17 A). The secondary structure obtained 
is presented in Fig. 3.17 B. MavA likely folds into a highly paired and thermostable structure due to the 















Figure 3.17 Prediction of the secondary structure of MavA sRNA. Multiple alignment of MavA RNA sequences from eight 
members of the Bcc and computed with LocARNA tool [146]. The black rectangle delineates the 12 nt that are likely to 
constitute MavA sequence, as predicted by MavA amplification with different primers (A). MavA sRNA consensus secondary 
structure with a free energy of - 59.46 kcal/mol was predicted by RNAalifold web tool [145] (B). Both figures are coloured 
following a structural conservation of the base pair: red - all sequences used to generate the consensus structure have the base 
pair; yellow – two types of base pairs can occur; green – three types of base pairs can occur. The saturation decreases with the 
number of incompatible base pairs.  
A search for MavA functional homologues within all the bacterial genomes with available sRNA 
annotations was performed using the sRNAMap web tool [144]. This tool searches for homologs base 
pairs within families of functional sRNAs. However, the use of these bioinformatic tools are challenging 
since the majority of the information present in the databases was obtained from studies performed with 
E. coli, Salmonella and Yersinia species. Therefore, there is a lack of information about functional 
sRNAs in β- proteobacteria and, particularly, in organisms from the Burkholderiales order. For MavA 
sRNA four functional homologues were predicted, however the identity values obtained were very low. 
The homologue with the lowest E-value was considered for further analysis (Fig. 3.18 A). Despite MavA 
and its predicted homologue (IstR-2) have only 12 nt shared in their sequences (Fig. 3.18 B), they present 
some similar features. IstR-2 is a 140 nt Hfq- dependent sRNA encoded in an intergenic region present 
in the reverse strand of E. coli K-12 MG1655 genome. Similar to MavA (Fig.3.6) IstR-2 is another 
sRNA encoded in the same region of IstR-1 and although both sRNAs are transcribed from different 
promoters, there is an overlap of their 3’ ends [175]. Besides encoding two sRNAs, this locus also 
encodes a toxic peptide (TisB) whose translation is inactivated by IstR-1 RNA and tisAB mRNA base 
pairing [175]. The transcription of IstR-2 is induced in response to DNA damage via the SOS system, 
being particularly expressed in the presence of a SOS response triggering factor - Mytomicin C (MMC) 
[175]. Unlike IstR-1, the role of IstR-2 sRNA in tisAB regulation is still unknown. Ortega et al. [176] 
have recently demonstrated that IstR-2 sRNA is upregulated in non-growing intracellular Salmonella 
enterica serovar Typhimurium and it is the least abundant sRNA when bacteria are extracellular. These 
findings suggest that this sRNA plays an important role in the adaptation of S. enterica Typhimurium to 
an intracellular lifestyle, although its target remains unknown. 
A         B 
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Figure 3.18 Results of the predicted homologue retrieved from the analysis with sRNAMap tool. Detailed information 
of the predicted homologue IstR-2 (A). Alignment produced by sRNAMap of MavA and IstR-2 sequences (B). Predicted 
structure of IstR-2 sRNA with a free energy of - 49.1 kcal/mol, retrieved from sRNAMap. The blue dots represent adenine-
uracil pairing and the red dots represent cytosine-guanine pairing (C). 
3.3.2 MavA putative targets in B. cenocepacia J2315 genome 
In order to functionally characterize MavA sRNA a search for putative mRNA targets was conducted. 
Each of the three chromosomes from B. cenocepacia J2315 was inspected for putative MavA targets. 
30 putative MavA targets with the lowest energy were predicted with TargetRNA2 [148] (Table 3.2) 
and RNAPredator [149] (Annex) web tools. From all the data obtained only a total of twelve targets 
















Table 3.2 Predicted mRNA targets of MavA in B. cenocepacia J2315 genome with TargetRNA2 tool [148]. 
 
 
The putative targets retrieved are involved in various cell functions, such as cell metabolism and 
inorganic ion transport; energy production and conversion; cell motility and secretion; signal 
transduction; lipids metabolism; cell envelope biogenesis and outer membrane; amino acid transport; 
DNA replication, recombination and repair; transcription and translation (ribosomal structure). Based 
on the analysis performed MavA appears to exert mainly a downregulation on its targets, since it was 
predicted a base pairing between the sRNA and the SD sequence/AUG codon (Fig. 1.3 C) [12]. 
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although both programs predicted a sRNA-mRNA interaction involving 10 to 20 nt. The first 13 to 36 
nt of MavA sequence were the most implicated in the predicted interactions. 
Phenotypes studies were performed to confirm if any of the predicted targets could be in fact a real target 
of MavA. 
3.3.3 MavA overexpression leads to S12 protein overexpression 
To confirm that MavA sRNA targets mRNAs, the sRNA was cloned on the constitutive expression 
vector pMLS7 containing the PS7 B. cepacia specific promoter [122]. The resulting plasmid, pMya2, 
was used to transform B. cenocepacia J2315 cells by triparental mating.  
The B. cenocepacia J2315 cells carrying the plasmid overexpressing MavA sRNA (pMya2) were 
incubated for 8 h in rich medium (LB) and for 24 and 48 h in minimal medium (M9). Samples of cell 
extracts prepared for each time point were analysed by Tricine-SDS-PAGE in order to study the 
influence of MavA overexpression in the total soluble proteins. A protein with an apparent molecular 
mass of 14 kDa was found as overexpressed by B. cenocepacia J2315 (pMya2) cells (Fig. 3.19) after 
incubation in LB medium and M9 medium. The levels of this protein increased only in the total soluble 
proteins samples of B. cenocepacia overexpressing MavA sRNA. This result suggests a possible role 
for MavA sRNA. 
 
Figure 3.19 Tricine-SDS-PAGE analysis of the total soluble proteins obtained from Bcc strains under study. Total soluble 
proteins were obtained from Bcc cells after an incubation period of 8 h in LB rich medium (A) and a 24 or 48 h incubation in 
M9 minimal medium (B) and diluted to a final OD640 nm of 0.4. Lanes: L – Molecular mass ladder (Unstained Protein Molecular 
Weight Marker, Fermentas); 1 - total soluble proteins from B. cenocepacia J2315; 2 - total soluble proteins from B. cenocepacia 
J2315 (pMya2) and 3 - total soluble proteins from B. cenocepacia J2315 (pMLS7); 4 and 6 - total soluble proteins from B. 
cenocepacia J2315 after an incubation period of 24 and 48 h in M9 medium, respectively; 5 and 7 - total soluble proteins from 
B. cenocepacia J2315 (pMya2) after an incubation period of 24 and 48 h in M9 medium, respectively. The arrows indicate the 
overexpressed proteins.  
Identification of the 14 kDa protein overexpressed was performed by mass spectrometry (MS) in the 
group of Professor Pedro Santos (Centre of Molecular and Environmental Biology, at the University of 
Minho). The sequencing results showed that the separated bands correspond to the S12 ribosomal 
protein, a component of the 30S ribosomal subunit encoded by rpsL gene [177]. 
With the parameters used, the locus BCAL0229, where the rpsL gene is located, was only predicted 
with the TargetRNA2 tool. This tool computed rpsL gene as a possible MavA target (Table 3.2), yielding 
– 9.31 kJ/mol of energy and a p-value of 0.032. Interestingly, the sRNA-mRNA interaction was 
predicted as occurring within the first 11 nt of MavA sequence, which are conserved among 
Burkholderia species. These results demonstrate that bioinformatic predictions are not 100% reliable 
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Additionally, MavA could exert a downregulation of rpsL gene, since the sRNA was predicted by 
TargetRNA2 to bind to the start codon of rpsL mRNA (Fig. 1.3 C). According to the experimental data 
obtained (Fig. 3.19) MavA sRNA does not exert a negative regulation, at least directly, on rpsL gene. 
Therefore, we hypothesized that MavA can be involved in an anti-antisense mechanism, negatively 
regulating a negative regulator of rpsL gene. E. coli MicF sRNA is a recent example of such mechanism, 
since it negatively represses the translation of leucine-responsive regulatory protein (Lrp), which in turn 
negatively regulates operons involved in amino acid catabolism and peptide transport [178]. 
High-resolution structural and biochemical studies of ribosomes and ribosomal complexes have 
characterized S12 protein as an important player in the process of translation, particularly to discriminate 
cognate from near-cognate tRNA species. Furthermore, S12 protein also promotes global changes in the 
small ribosomal subunit favouring its transition to a domain “closure” during the translation cycle 
progression [179,180]. 
The best characterized phenotype involving S12 protein and rpsL gene was first described in E. coli 
[177]. Point mutations in rpsL gene and, consequently, in S12 protein resulted in a reduced sensitivity 
to the antibiotic streptomycin, a broad-spectrum aminoglycoside that interacts with the 30S ribosomal 
subunit, leading to a misreading of the mRNA [181] and affecting ribosomal proofreading [182]. More 
recently, the spontaneous mutations responsible for the increase of bacterial resistance to this 
aminoglycoside were shown to be often accompanied by a decrease of the bacterial resistance to 
tetracyclines [183,184]. Tetracycline functions differently from streptomycin, blocking the attachment 
of aminoacyl-tRNA to the ribosomal acceptor (A) site [185]. 
To investigate if MavA sRNA overexpression could influence S12 protein and consequently 
streptomycin and tetracycline resistance, the susceptibility to these antibiotics was determined by broth 
micro dilution technique based on standard techniques described by Andrews [140]. B. cenocepacia 
J2315 (pMLS7) and B. cenocepacia J2315 (pMya2) strains exhibited a MIC higher than 1,024 µg/mL 
for streptomycin. It should be noted that B. cenocepacia J2315 strain is highly resistant to this antibiotic. 
The highest concentration tested in this experiment was 1,024 µg/mL and the WT strain had a MIC 
value higher than this concentration. Thus, if MavA sRNA affects S12 protein levels, causing increased 
resistance to antibiotics we were not able to detect them. As abovementioned, certain types of mutations 
in this protein have been described as frequently associated to a higher susceptibility to other antibiotics, 
such as tetracycline. The MIC values obtained for B. cenocepacia J2315 (pMya2), B. cenocepacia J2315 
(pMLS7) and B. cenocepacia J2315 strains were identical, 64 µg/mL. Moreover, the expression vector 
used in this study did not influence the bacterial resistance to the tested antibiotics. Together, these 
results suggest that the overexpression of MavA sRNA does not affect the resistance to the tested 







3.3.4 MavA overexpression does not affect B. cenocepacia J2315 ability to grow in minimal 
medium 
The growth ability of the WT and B. cenocepacia J2315 overexpressing MavA strain was compared in 
cultures growing in minimal medium (M9) at 37 ºC with orbital agitation. No differences were observed, 
with both strains showing similar growth curves and indicating that MavA overexpression does not 
affect the ability of the strain to grow on minimal medium (Fig. 3.20). 
 
Figure 3.20 Growth curve comparison. Comparison of B. cenocepacia strains J2315 (■) and B. cenocepacia J2315 (pMya2) 
(▲) growth in M9 medium with orbital agitation at 37 ºC (n=3). Values represent mean  SD. 
3.3.5 MavA overexpression affects B. cenocepacia J2315 resistance to heat-shock 
Some trans-acting sRNAs have been discovered to be induced under heat-shock conditions (reviewed 
in [186]). MicA sRNA was first described in E. coli and is an example of a sRNA whose expression is 
highly induced under this type of stresses [187], acting through the repression of the translation of omp 
mRNAs [188,189]. 
To test the hypothesis that MavA sRNA influences B. cenocepacia J2315 resistance to heat-shock, the 
resistance of B. cenocepacia J2315, B. cenocepacia J2315 (pMLS7) and (pMya2) strains to thermal 
stress was evaluated. Aliquots of cultures of each strain were incubated at 50 ºC for 5 and 15 min. After 
these periods of exposure to 50 ºC, each culture was serially diluted and plated and bacterial survivors 
were counted. Although it was not possible to perform a statistical analysis with the results obtained, 
since only two replicates were performed, it is possible to visualize an increase in the number of bacterial 
survivors in the strain overexpressing MavA sRNA (Fig. 3.21). After a short-incubation period of 5 min 
under this stress condition, B. cenocepacia J2315 (pMya2) strain shows approximately a 1.4-fold 
increase in the percentage of bacterial survival when compared to B. cenocepacia J2315 (pMLS7), while 
B. cenocepacia J2315 (pMLS7) shows approximately a 1.2-fold increase in the percentage of bacterial 
survival when compared to the WT strain. A 3-fold increase in the exposure time at 50 ºC results in a 
general decay in the percentage of bacterial survivors, with the WT and B. cenocepacia J2315 (pMLS7) 
strains showing no differences between the percentage of survivors. Remarkably, B. cenocepacia J2315 
(pMya2) strain shows approximately a 10-fold increase in the percentage of bacterial survivors when 
compared to the result obtained with B. cenocepacia J2315 (pMLS7) strain (Fig. 3.21). 
According to these results, MavA sRNA increases bacterial resistance to heat-shock stress (50 ºC). 




Figure 3.21 MavA overexpression in B. cenocepacia J2315 cells increases 
its resistance to heat-shock stress. Cells from exponentially growing 
cultures were harvested and were exposed for 5 and 15 min to 50 ºC. Aliquots 
with 100 µL were then spread onto the surface of LB plates. After 24 h at 37 
ºC, the number of CFUs/ mL was counted and the relative number of bacterial 
survivors was calculated. Black bars represent B. cenocepacia J2315 strain; 
dark-grey bars represent B. cenocepacia J2315 (pMLS7) strain and light-grey 
bars represent B. cenocepacia J2315 (pMya2) strain. Values represent mean 
 SD and are expressed as percentages relative to non-exposed control cells 
(n=2).  
 
3.3.6 MavA overexpression does not affect biofilm formation 
The capacity of a bacteria to form biofilms indicates a higher virulent behaviour and ability to cause 
persistent infections [109]. Moreover, biofilms have also been associated to an enhanced in vitro 
antibiotic resistance [110]. The ability of Bcc strains under study to form biofilms was compared after 
24 and 48 h in LBB medium at 37 ºC. Although it was possible to observe a slightly increase in the 
amount of biofilms formed by B. cenocepacia J2315 (pMya2) when compared to B. cenocepacia J2315 
(pMLS7), no differences with statistical significance were observed (Fig. 3.22). This result suggests that 





Figure 3.22 Biofilm formation by B. cenocepacia J2315 (black 
bars), B. cenocepacia J2315 (pMLS7) (dark-grey bars) and B. 
cenocepacia J2315 (pMya2) (light-grey bars) strains in 
polystyrene microtiter plates. Biofilm formation was quantified after 
24 and 48 h of incubation at 37 ºC in LBB medium without agitation. 
Values represent mean ± SD. Statistical analysis performed with the 
unpaired t- test (n=3). 
 
Despite MavA does not influence biofilm formation, the effect of this sRNA in two distinct types of 
motility were tested, namely in swimming and twitching motilities (Fig. 3.23). Swimming motility is an 
individual type of motility characterized by rotating flagella [163], whereas twitching motility occurs 
by extension and retraction of type IV pili [164]. Although none of the components necessary for these 
types of motility were predicted as possible MavA targets (Table 3.2), the results obtained for flagellar-
mediated swimming motility suggest that overexpression of this sRNA can slightly increase this type of 
motility (Fig. 3.23 A). However, more experiments must be performed to confirm this hypothesis. 
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Figure 3.23 MavA sRNA influences swimming (A) and twitching (B) motility. Bars show the colony diameter obtained for 
B. cenocepacia J2315 (black), B. cenocepacia J2315 (pMLS7) (dark-grey) and B. cenocepacia J2315 (pMya2) (light-grey), 
after 48 h at 37 ºC (A) and 72 h at 37 ºC (B). Values represent mean ± SD. Statistical analysis performed with the unpaired t- 
test (n=2). 
3.3.7 MavA sRNA overexpression does not affect the ability of B. cenocepacia J2315 to kill the 
nematode C. elegans significantly 
To investigate the role of MavA sRNA in B. cenocepacia J2315 virulence, slow-killing experiments 
using the infection model C. elegans were performed according to Sousa et al. [135]. The C. elegans 
mutant strain DH26 was used in this study since it is unable to reproduce at 25 ºC, being a suitable strain 
to count nematodes without progeny interference. The E. coli OP50 strain was used as a control in these 
experiments due to its attenuated virulence towards this nematode when compared to B. cenocepacia 
J2315 [119]. 
Over the five-day period of this experiment, the population of worms feeding on B. cenocepacia J2315 
strain and their derivatives harbouring pMLS7 or pMya2 showed a gradual decrease in the number of 
surviving worms (Fig. 3.24). Remarkably, in the last day only 2% of the nematodes were detected as 
being alive. B. cenocepacia J2315 strain carrying the expression vector pMLS7 induced a striking 
reduction in the initial population during the first two days. In fact, at day 1 the percentage of surviving 
worms was 50% and in day 2 only 30% of the worms had survived. A lower decrease in the initial 
population was observed for the WT strain that revealed 60% and 40% of surviving worms at day 1 and 
day 2, respectively. Noteworthy, after day 3 this trend was reversed and the WT strain showed a higher 
decrease when compared to those feeding on B. cenocepacia J2315 (pMLS7). However, there was no 
significant differences between the B. cenocepacia J2315 strain carrying the expression vector pMLS7 
and the WT strain. 
The B. cenocepacia J2315 strain overexpressing MavA sRNA (pMya2) exhibited during the five-day 
period a slightly reduced ability to kill the nematode (Fig. 3.24). After day 1 and day 2, the percentage 
of surviving worms feeding on B. cenocepacia J2315 (pMya2) was approximately 8% higher than the 
percentage of surviving worms feeding on B. cenocepacia J2315 (pMLS7). At days 3, 4 and 5 the 
difference between the percentage of surviving worms obtained for the strain overexpressing MavA and 
for B. cenocepacia J2315 (pMLS7) decreased to approximately 5%. A higher percentage of surviving 
worms was observed for populations feeding on B. cenocepacia J2315 (pMya2). 
Although no statistical significance was obtained, these results suggest a less virulent behaviour of B. 
cenocepacia J2315 (pMya2) strain. This behaviour could be explained by the presence of growth defects 
in the strain B. cenocepacia J2315 (pMya2), however at least under starvation no significant differences 
were observed (Fig. 3.20). 
Overall, these results suggest that MavA sRNA appears to play no significant role on B. cenocepacia 










































an intracellular lifestyle, similarly to its homologue, IstR-2 sRNA [176]. To confirm these hypotheses 
further experiments have to be performed. 
 
Figure 3.24 Comparison of E. coli OP50 (purple bars), B. cenocepacia J2315 (black bars), B. cenocepacia J2315 (pMLS7) 
(dark-grey bars) and B. cenocepacia J2315 (pMya2) (light-grey bars) ability to kill the nematode C. elegans. Values 
represent mean  SD and are expressed as percentages relative to the initial number of hypochlorite-synchronized L4 larvae of 
C. elegans DH26 inoculated (between 18-30). Statistical analysis performed with the unpaired t- test (n=2). 
  




































4. CONCLUDING REMARKS AND FUTURE PERSPECTIVES   
Several Bcc strains present beneficial effects due to their diverse abilities that include promoting plant 
growth, production of antifungals and degradation of xenobiotics (reviewed in [59]). However, they 
have also arisen as highly problematic opportunistic pathogens in vulnerable patients, mainly CF 
patients [60,81,95–97]. Actually, in these patients Bcc infections are often associated with a fatal 
outcome - “cepacia syndrome” [60]. Moreover, the resistance of several Bcc species to the majority of 
clinically available antimicrobials [93] and the recognition of some Bcc strains as emergent nosocomial 
pathogens in oncology patients [69,97] highlight the need of understanding the mechanisms underlying 
the Bcc pathogenesis and virulence, in order to identify novel therapeutic targets to combat life-
threatening infections. 
sRNAs have been widely discovered among the three domains of life (Bacteria, Eukarya and Archaea) 
and they are known to play important roles in bacterial virulence, acting mainly at the posttranscriptional 
level of gene expression regulation [9] (reviewed in [10]). 
In this study, we report the presence of a non-annotated ORF and a sRNA, named ORF3 and MavA, 
respectively, overlapping at least 100 nt, in the 555 bp IGR of B. cenocepacia J2315 chromosome 1. 
These genetic elements were identified in the B. cenocepacia J2315 mutant SJ2, obtained by plasposon 
insertion. Stress resistance, mobility and virulence assays in the nematode C. elegans, as well as 
extensive bioinformatics analyses were performed in order to characterize the sRNA and the 
hypothetical ORF. 
ORF3 protein is predicted to be composed of 93 aa residues and its encoding ORF was found to be 
conserved among the Burkholderia genus. Moreover, ORF3 protein sequence was identical to that of an 
annotated ORF of B. multivorans and to five annotated ORFs of B. pseudomallei species. Bioinformatics 
analyses and RT-PCR experiments showed that this hypothetical protein is affected by the plasposon 
insertion in B. cenocepacia SJ2 and it appears to play an important role in B. cenocepacia J2315 stress 
response. This conclusion was built due to the fact that its mutation leads to an increased sensitivity of 
B. cenocepacia J2315 to thermal stress and enhanced cell lysis rate when exposed SDS. In addition, B. 
cenocepacia SJ2 mutant strain also showed increased cell hydrophobicity and, consequently, a higher 
ability to form biofilms. Regarding the antimicrobials effects, the B. cenocepacia SJ2 mutant strain 
revealed an enhanced sensitivity to two -lactams (ceftazidime and imipenem) and to the antibiotic 
tetracycline. Overall these results suggest that this hypothetical protein could be implicated in the 
maintenance of outer membrane integrity. Moreover, ORF3 protein was also shown to be involved in 
the virulence of B. cenocepacia J2315 strain.  
The sRNA identified in this study (MavA) comprises approximately 179 bp and was found to be widely 
conserved among the Burkholderia genus. IstR-2 was identified has being the MavA functional 
homologue, however its biological role remains unknown. Experiments regarding the effect of MavA 
overexpression in total soluble proteins were performed and this work demonstrates that the levels of 
the ribosomal protein S12, a component of the 30S ribosomal subunit, are increased when MavA is 
overexpressed. However, no differences were observed in the resistance and susceptibility to the 
antibiotics streptomycin and tetracycline, when B. cenocepacia J2315 overexpressed MavA. These 
findings indicate that MavA does not affect S12 protein-mediated resistance to these antimicrobials. Our 
preliminary results suggest that the MavA sRNA might play a direct or indirect role in swimming 
motility, while no significant differences were observed in the amount of biofilms formed. However, 
MavA sRNA appears to be important for the survival of B. cenocepacia J2315 when exposed to heat-
shock (50 ºC). Our results also demonstrate that MavA sRNA is not involved in the virulence of this 
strain.  
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We hypothesize that MavA might be involved in an anti-antisense mechanism, where it negatively 
regulates a negative regulator of rpsL gene. However, if the observed phenotypes result from the direct 
or indirect influence of MavA remains unknown.  
A few sRNAs have been found to be generated from 3’ regions of known mRNAs, using an internal 
promoter, or resulting from an internal processing of the initial mRNA (reviewed in [50]). The inhibition 
of the transcription of ORF3 but not MavA sRNA, caused by the plasposon insertion, together with the 
presence of a putative promoter for MavA sRNA in the ORF3 region support the hypothesis that these 
genetic elements are totally independent from each other. Thus, as described for these 3’ UTR sRNAs, 
MavA is likely benefiting from the ORF3 terminator, since the predicted Rho-independent terminator is 
located 55 bp downstream mavA encoding sequence.  
The possibility that these elements represent a novel toxin-antitoxin system was considered. In the 
systems already characterized, the RNA acts as an antitoxin and the protein functions as a toxin 
responsible for membrane changes are described for proteins causing membrane lysis (reviewed in [30]). 
However, our results suggest that ORF3 protein is implicated in the maintenance of membrane integrity. 
In the recent years, a new class of proteins with a standard size of 50 aa, named small proteins 
(sproteins), have been widely identified through the detection of mutations in putative IGRs that 
interrupt non-annotated ORFs encoding these proteins or through the disclosure that some small and 
regulatory RNAs can also encode these small proteins (reviewed in [190]). These proteins can be 
involved in diverse functions, such as the modulation of cell membrane features (thickness or fluidity), 
the modulation of different pathways, and can also act as chaperones of both metals and nucleic acids 
(reviewed in [190,191]). Interestingly, some of the sproteins features coincide with the properties of 
ORF3 protein, since in the stress assays performed we observed that this protein is likely involved in 
the maintenance of the outer membrane integrity. Moreover, sproteins functioning as chaperones that 
promote sRNA-mRNA interactions have high values of pI, which means that the neutral protein form is 
present under more basic conditions (reviewed in [191]). In fact, similarly to these chaperones the 
zwitterionic form of the hypothetical protein encoded by ORF3 also seems to be dominant in a basic 
environment (high pH values) since the bioinformatically predicted pI is 10.20. Thus, it is possible that 
ORF3 protein belongs to the class above described. 
Future work will comprise stress experiments involving MavA sRNA silencing and electrophoretic 
mobility shift assays (EMSA) for the assessment of MavA binding affinity to putative targets, such as 
rpsL mRNA and eventually to Hfq protein. In fact, the Hfq protein is often associated with sRNAs 
originated from the 3’ end of known mRNAs. Furthermore, the stability of MavA sRNA in the B. 
cenocepacia SJ2 strain should be evaluated in RNA decay experiments. The functional characterization 
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